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ABSTRACT
This project examines the effects of HCMV infection on cell proliferation, differentiation, 
as well as on the growth factor production of myeloid cells during the myelopoiesis. The 
major focus is on the effects of the challenge of HCMV AD 169 strain on the proliferation 
and inhibitor production of U-937 and THP-1 cells in the presence or absence of retinoic 
acid.
In the present study, promonocytic U-937 and THP-1 cells were treated with 500 nM 
retinoic acid. These two cell lines are known as leukemia cells which are blocked at a 
relatively late stage along the myelopoiesis. Treatement of both cell lines with retinoic 
acid for a period of 6 days could markedly inhibit the cell proliferation, as measured by 
the counts of viable cell number and the level of [3H] TdR incorporation. Concomitant 
with the retinoic acid-associated suppression of cell proliferation was the appearance of 
indented, kidney shaped nuclei and a time-dependent increase in the percentage of cells 
reducing nitroblue tétrazolium , which are characteristic for differentiated monocytes.
Promonocy tic U-937 and THP-1 cells spontaneously produced factors which inhibited the 
proliferation of murine thymocytes primed with phytohaemagglutinin and rIL-2. However 
this suppression became less effective when both cell lines were differentiating in the 
presence of retinoic acid.
HCMV challenge could suppress the proliferation of promonocy tic U-937 and THP-1 
cells. This suppression effect appeared to be independent of the infectivity of the virus as 
both infectious and UV-inactivated HCMV suppressed the cell proliferation to a similar 
extent. Challenge of U-937 and THP-1 cells with HCMV could disturb their inhibitor 
production and the extent of the disturbation was very likely dependent upon the 
intracellular status of both cell lines in the presence of RA.
V I
In conclusion, this project expands our understanding of the highly complex interaction 
which occurs between cells of U-937 and THP-1 and HCMV during the process of cell 
proliferation and differentiation.
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Introduction
1
1.1 HUMAN CYTOMEGALOVIRUS
Human cytomegalovirus (HCMV) is the largest species-specific double-stranded DNA virus 
in the human herpesvirus group (Apperley and Goldman, 1988). As an ubiquitous 
infectious agent, HCMV infects the majority of the people during their lives. Symptoms 
occurring after a HCMV infection depend on the immune state of the individual.
1.1.1 Classification
Cytomegalovirus (CMV) is a member of the family herpesviridae. It is further grouped into 
the subfamily p-herpesvirinae. CMV exhibits a relatively protracted replication cycle, a 
slowly developing cytopathology characterised by cytomegaly, and a relatively restricted 
host range (Staczek, 1990). Further classification of CMV into genera and species depends 
on the animal species from which the virus was isolated, the serologic cross-reactivity of the 
virion antigens and the nature of the sequence arrangement and homology to the reference 
genomic deoxyribonucleic acids (DNAs) (Spector and Spector, 1984; Alford and Britt, 
1985; Staczek, 1990).
1.1.2 Historical perspective
CMV characteristically produces cell enlargement with intranuclear and perinuclear 
inclusions which can be detected in the salivary glands, lungs, liver and kidneys, indicating 
a wide range of host cells in vivo. The characteristic cytomegalic cells were first described 
by Jesionek and Kiolemenoglow in 1904 from their findings of those enlarged cells in 
biopsies of the organs of an 8-month foetus. This was followed by a great number of 
similar reports. These earlier reporters, however, regarded the inclusions as of protozoan 
or syphilitic origin (von Glahn and Pappenheimer, 1925). The first descriptive report of a 
disease process possibly caused by HCMV infection appeared in 1925 when " large 
protozoan-like cells " were described in the kidney of a stillborn infant (von Glahn and
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Pappenheimer, 1925). The earlier term " cytomegalic inclusion disease " (CID) was given 
to the disease even before the causative agent was isolated. In 1926, Cole and Kuttner 
provided the first experimental evidence that the CID was caused by a filterable virus which 
was coined as salivary gland virus detected in the submaxillary glands of guinea pigs 
(Rapp, 1983). With the development of in vitro tissue culture methods, the initial isolation 
of HCMV occurred in 1956 and 1957, from which the most widely used laboratory strains 
AD 169 (Rowe et al. , 1956), Smith (Smith, 1956) and Davis (Weller et al. , 1957) were 
established. The name of the virus was then changed from the original salivary gland virus 
to cytomegalovirus, a name taken from Greek (cyto-: cell, megalo-: large) to describe the 
characteristic cytopathic effect (CPE) induced in the virus infected cells. An even more 
precise term for this virus in the terms of virological nomenclature, human herpesvirus 5, 
was proposed by the report of the Herpesvirus Study Group of the International Committee 
for the nomenclature of Viruses in 1973 (Roizman, 1973). As a result of the advance of 
increasingly sophisticated techniques in molecular biology and immunology, the study of 
HCMV infection has proceeded to the molecular dissection of the structure of HCMV 
DNA and of the regulatory mechanisms for HCMV gene expression.
1.1.3 Properties of HCMV
i) Morphology
The HCMV virion consists of a densely staining DNA core packaged with proteins and 
encapsulated into an icosahedral protein capsid comprising 162 capsomers. A tegument 
separates the capsid from a lipid bilayer outer membrane (envelope). The size of the HCMV 
virion varies from 100 - 150 nm.
The HCMV genome is a double-stranded linear DNA with 57% G+C content Its molecular 
weight is approximately 150 x 106 Daltons (* 240 kilo-bases). There are a long and a short 
segment of unique nucleotide sequences, each of which is bounded by a pair of inverted 
repeat sequences, named terminal repeats and internal repeats (TR and IR). Because of the
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different arrangements of TR and IR during viral replication, four different molecular 
isomers exist in equimolar concentrations.
There is little cross-reactivity among CMV isolates from different species. However, 
HCMV is antigenically heterogenous with extensive cross-reactivity being observed among 
human CMV strains, ranging from 80 - 90% (Rapp, 1983; Apperley and Goldman, 1988). 
This heterogeneity is not due to geography, age of hosts or clinical diseases (Rapp, 1983).
ii) Epidemiology
HCMV is endemic throughout the world and infects individuals from diverse geographic 
and economic backgrounds. It can be transmitted through body fluid, such as saliva, breast 
milk, urine, semen, vaginal secretions etc. and also via blood transfusions and transplanted 
organs (Passet et al., 1978; Kinney et al.y 1985).
Socio-economic situations affect the epidemiology of HCMV. HCMV infection is prevalent 
where the economic situation declines (Apperley and Goldman, 1988). Transmission of 
HCMV to the foetus during pregnancy can occur transplacentally following maternal 
infection (Spector, 1984) and sometimes causes serious sequelae, such as CID (Kinney et 
al., 1985). Following a high rate of HCMV transmission among young infants of six 
months to 2 years of age (Kinney et a l , 1985), there is a higher HCMV transmission rate in 
teenagers and adults with increased sexual activity (Spector and Spector, 1984), indicating 
that intimate contact is a transmission pathway in HCMV epidemiology. It is generally 
believed that transplanted organs from HCMV donors are a major source of HCMV 
transmission in those HCMV seronegative recipients. However in the HCMV seropositive, 
asymptomatic recipients, whether the occurrence of symptoms of HCMV infection is due to 
a reactivation of the originally latent infected HCMV or a HCMV reinfection remains 
controversial. In this case, the HCMV serologic status of the recipient is a dominant factor 
associated with the risk of HCMV reactivation (Cuervas-Mons et al., 1990). The extent to
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which previous infection protects against or modifies subsequent infection is not known 
(Onorato and Morens, 1985).
iii) Physical properties
Several physical properties of HCMV are common to all CMVs and include high species 
specificity, tight association with the host cells, low virus production (104 - 107 in cell 
cultures), slow development of CPE (18 hrs in fibroblasts), sensitivity to ether and 
phytohemagglutinin (PHA), resistance to trypsin, lability at 37°C and inactivation at 56°C 
(Rapp, 1983).
iv) Biological properties
Initiation of HCMV infection may require initial interaction with cell surface heparin sulfate 
(Compton et al., 1993). One suggested cellular receptor for HCMV infections is human 
leucocyte antigen (HLA) class I molecules expressed on the cell surface (Grundy et al., 
1987; Beck and Barrell, 1988). HCMV particles have been found to bind b2m- This might 
promote infectivity by a binding to HLA alpha-chain on cell membranes. But results from 
Beersma et al (1993) experiments do not support the suggestion that HLA-B27 might act as 
an HCMV receptor. Other receptors proposed are a 32 - 34 Kd glycoproteins presented on 
a B lymphoblastic cell line and human diploid fibroblasts (Adlish et al., 1990; Nowlin et al., 
1991), and 92.5 Kd glycoproteins present on fibroblasts (Keay et al., 1989; Rasmussen et 
al., 1991).
After entering the host cells, HCMV replication proceeds in a " cascade " fashion, in which 
synthesis of each class of viral proteins permits the synthesis of the subsequent class 
(Apperley and Goldman, 1988). The 240 kilobase HCMV genome is capable of coding for 
about 200 proteins. Because of extensive post-translational modifications, HCMV proteins 
are very complex. The first viral genes transcribed by the host cell RNA polymerase II are 
immediate early antigens (IEA) which control subsequent viral gene expression. IEAs are
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expressed independently of any preceding viral protein synthesis within 2 hour post­
infection (p.i.). These proteins are attracting increasing attention because their regulation is 
probably involved in reactivation of latent HCMV infection (Maeda-Takekoshi et al., 1993; 
Fumari et al., 1993). IEA expression is essential for the subsequent expressions of the early 
antigens (EA), at 2 to 24 hour p.i. and late antigens (LA), after 24 hour p.i.. This 
sequential order of HCMV gene expression is very similar to other herpesvirus gene 
expression.
Early antigens include the proteins involved in the viral DNA replication process. Viral 
DNA replication can only occur after the production of IEAs and EAs. It starts at 
approximately 12 hours after a high-multiplicity infection. There is, however, a 72 - 96 
hour long eclipse period prior to the occurrence of maximum viral DNA replication. 
Although cellular DNA synthesis is activated after HCMV infection, this activation is 
apparently not essential for the synthesis of viral DNA or viral antigen proteins (Stinski, 
1983).
HCMV replication is inherently slow. The late antigens are structural proteins of the virus 
and are expressed after viral DNA replication and the assembly of the capsids occurs at 
about 72 hrs p.i.. Progeny HCMV particles may utilise early endosomal cistemae for their 
envelopes (Tooze et al., 1993). There is little cell free virus with infection spreading 
predominantly to contiguous cells. Cell death occurs approximately 5 - 8  days after the 
infection.
HCMV is highly species specific and productive replication can only be completed in its 
permissive host cells. In vitro, productive HCMV infection mainly occurs in human 
fibroblasts, although yields of HCMV from challenged human epithelials cells (Stinski, 
1983) and under some particular situations from monocytes and macrophages have been 
reported (Brautigam et al., 1979). HCMV encounters both non-permissive and permissive
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cells in the human host. Viral regulatory mechanisms or the physiological state of the cell, 
or both, may influence whether the infection is productive or non-productive. Furthermore, 
a non-productive cell may favour persistent infection or latency of the viral genome or both 
(Stinski, 1983).
1.1.4 Symptoms of HCMV infections
Asymptomatic primary HCMV infection of immunocompetent individuals involves a 
mononucleosis-like syndrome. There is sometimes a prolonged, unapparent infection 
during which the virus remains latent in multiple cells and tissues throughout the body 
without causing noticeable damage or clinical illness.
Viral infection is considered to be a putative factor affecting the induction of auto-immune 
diseases. As a ubiquitous infectious agent, the role of HCMV infection in individuals with 
auto-immune diseases is debatable. There is a striking homology between a human 
neutralising IgGl anti-CMV antibody and IgM rheumatoid factors of the Wa idiotypic 
family in both the amino acid and nucleotide sequences of the variable regions of the heavy 
and light chains (Newkirk et al., 1988). One human pancreatic islet cell specific 38 Kd 
auto-antigen was also identified by CMV induced monoclonal islet cell autoantibody (Pak et 
al., 1990). However, it remains unclear whether HCMV contributes to auto-immune 
diseases in a genetically susceptible host or whether HCMV infection of an individual with 
auto-immune disease causes auto-antibody production. Alternatively the structural 
homology may be coincidental and only reflect the limited human germ line antibody 
repertoire.
In immunocompromised persons, HCMV is frequently an opportunistic pathogen, causing 
clinical illness with serious morbidity and mortality (Osborn, 1981; Onorato and Morens, 
1985).
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1.1.5 Potential mechanisms of HCMV pathogenesis
Depending on the cellular properties and immune responses to the virus infections, there are 
several mechanisms by which HCMV infections can result in pathology in its host cells.
i) Lysis o f the infected cells
The infected cells die at the end of the viral replication cycle, and the progeny virus is 
released. This occurs with cells which are permissive for HCMV infection, such as 
fibroblast cells. Although HCMV replicates very slowly, more cell-associated than 
extracellular viruses are produced, and many more defective than infectious particles are 
generated (Alford and Britt, 1985). HCMV is cytopathic, causing severe cell destruction 
and resulting in cellular dysfunctions.
Evidence suggests that host defence mechanisms may be partly responsible for the 
cytopathology in vivo (Ho, 1990). The expression of HCMV directed IEA, EA and LA, 
either as intact proteins or as peptide fragments presented on the host cell surface in vivo 
would render the cell vulnerable to attack by cytotoxic T lymphocytes (Tc) or antibody- 
dependent cell-mediated cytotoxity (ADCC) (Boryssiewiez et al., 1983). Thus the damage 
could be elicited by the virus but caused by the host cell-mediated immune responses.
ii) Transformation o f infected cells
As a DNA virus, HCMV bears properties of an oncogenic virus. HCMV in vitro is able to 
stimulate cellular DNA and RNA synthesis and produce high levels of the oncogenic marker 
ornithine decarboxylase (Jeor e ta l,  1974; Janaka et al., 1975; Isom, 1979), and induce 
transformation of animal and human cells by both infectious and UV-irradiated viruses 
(Geder et a l, 1977). Cellular high molecular weight DNA (HMW DNA) extracted from 
HCMV infected cell cultures demonstrated a substantial increase in transforming activity 
after introduction into hamster embryo fibroblasts relative to HMW DNA extracted from 
mock-infected cells (Boldogh et a l, 1993). But HMW DNA isolated from HCMV infected
8
cells after initiation of viral DNA synthesis demonstrated a significant decrease in the 
induction of morphologically transformed foci (Boldogh et a l ,  1993). Using cloned 
fragments of HCMV DNA and transfection of 3T3 cells, the oncogenicity was mapped to a 
small fragment (2.9 kilo-bases) which was heavily transcribed during IE protein production 
(Nelson et al., 1982; 1984). In vivo, HCMV has been proposed as a candidate for the 
oncogenic virus involved in AIDS patients with Kaposi's sarcoma (KS), which is thought to 
be of endothelial cell origin. But attempts to demonstrate HCMV DNA in these cells have 
been unsuccessful. Data from Clinical studies in the oncogenesis of cervical cancer 
suggested that a synergistic interaction may occur between HCMV and human papilloma 
virus (Shen et al., 1993; Huang et al., 1993). Whether HCMV is a human carcinogen, co­
carcinogen, or simply a passenger in cancerous cells remains debatable, as HCMV can 
asymptomatically infect its host cells in a large population of normal people. There is at 
present no definitive evidence that HCMV infection transforms immunocomponent cells in 
experimental animals or human beings.
iii) Persistent and latent infections
It has been known for a long time that lytic viruses show wide differences in their replication 
strategies. Viruses adapted for latency in certain differentiated cells, with only occasional 
lytic multiplication, appear to have a higher regulatory complexity than viruses with a purely 
lytic lifestyle (Klein, 1989). The latency sometime is a cell differentiation-dependent 
phenomenon. Klein (1989) reported that the major latent EBV virus-carrying cellular 
prototypes differ in the expression of "latent viral genes", which are regulated by 
differentiated host cell mechanisms. Cell differentiation may also contribute to the 
establishment of persistent or latent infections with HCMV. A viral or host-cell factor(s) 
necessary for HCMV replication may present in the process (Stinski, 1983). In the absence 
or presence of an extremely low level of this factor, HCMV may not complete its replication
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cycle, resulting in a latent state in its non-productive cells. Such could be the case in 
monocytes and lymphocytes, which are possible reservoirs for latent HCMV infection. 
During the proliferation/differentiation process, this necessary factor might be produced, 
causing monocytes/lymphocytes to switch from non-productive cells to productive cells, and 
allowing HCMV to perform the complete viral replication cycle and then get out of the " 
harbour " (Figure 1) (Dutko and Oldstone, 1981; Stinski, 1983; Weinshenker et al., 1988; 
Dudding et al.y 1989; Schmidt and Woodland, 1990).
Figure 1
Proposed pathways of the CMV genome in nonproductive and productive cells (Stinski, 
1 9 8 3 ).
Virus + cell
i
viral genome
__________ in the nucleus
1 of the host cell
Non-productive 
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4
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1.1.6 Interactions between HCMV and the immune system
HCMV, as a ubiquitous virus, displays a two-sided relationship with the immune system 
during infection of human beings — the virus being controlled by the immune response and 
yet capable of producing immunosuppression itself (Ho, 1982). By infecting immuno­
competent cells, HCMV affects the immunity at multiple levels of the immune system, 
including antigen presentation [e.g. the alteration of the expression of self major 
histocompatibility complex (MHC) class I and II molecules]; production of biologically 
active substances, such as interleukin-1 (IL-1) and IL-2; production of inhibitory factors,
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such as IL-1 inhibitor; deficiency in haematopoiesis in bone marrow and thymus; direct cell­
cell inhibition, such as suppressor T cells, and a combination of these processes. Thus, 
HCMV infection directly or indirectly disturbs the finely tuned functioning of the immune 
system, resulting in immunosuppression or immunopathologic effects.
i) T lymphocytes
The cellular immune system carries out numerous functions that are very important in 
controlling HCMV infections. Most of our knowledge about the effects of HCMV infection 
on the human immune system are obtained by studying immunocompromised patients, who 
have profound defects in cell mediated immune responses but nearly normal levels of 
circulating antibodies. Symptomatic HCMV infections are common in these patients.
T cells have been generally grouped into three functional classes: helper T cells (Th), which 
stimulate immune responses; suppressor T cells (Ts), which diminish the immune reactions 
started by Th cells; and cytotoxic T lymphocytes (Tc), which are engaged in the direct lysis 
of the cells expressing viral antigens associated with self-MHC class I molecules 
(Goverman et al., 1986). Responses of Tc cells to HCMV represent the predominant 
mechanism by which hosts resist HCMV infections. HCMV specific Tc cells are present in 
peripheral blood in normal asymptomatic seropositive individuals (Borysiewiez et a l , 
1988). There are also subsets of such Tc cells, specific for HCMV antigens expressed at 
different stages of the virus replicative cycle (Borysiewiez et a l , 1988). Yamashita et al 
(1993) demonstrated HCMV infection resulted in a marked reduction in the surface 
expression of class I major histocompatibility complex (MHC) antigen on human embryonic 
lung fibroblasts. This mechanism would favour HCMV in limiting the presentation of the 
potentially immunogenic IE proteins, which may preclude IE-specific Tc from providing 
protective immunity to HCMV infection (Gilbert et al., 1993).
11
Information from clinical observations has revealed that the activity of both Th and Tc cells 
is depressed in patients with symptomatic, primary HCMV infections, whereas it appears to 
be activated in patients with subclinical CMV infections (Alford and Britt, 1985). Although 
these patients can have prior immunity to heipes simplex virus and varicella-zoster virus, 
their mononuclear cells responded poorly to antigens prepared from these viruses and the 
proliferating response to these antigens returned to normal in parallel with the development 
of a normal response to HCMV (Levin et a l , 1979).
Some reports have shown that in HCMV infections, the total number of T cells and the 
lymphocyte proliferation responses to PHA and nominal antigens other than HCMV are 
normal (Gehrz et al., 1987; Roenhorst et a l , 1988). Carney and Hirsch (1981) 
demonstrated that in HCMV induced mononucleosis, normal and HCMV infected 
lymphocyte population have both suppressor and helper functions, but in lymphocytes 
obtained from patients with HCMV mononucleosis, the balance was shifted toward more 
suppressor and less helper cell activity. Spector and his co-workers (1984) found that 
there was an absolute increase in the amount of Tc and a decrease in Th cells, thus resulting 
in a reduced or even an inverted ratio of Th/Tc cells. In in vitro experiments, the Ts subset 
also expanded after virus challenge of lymphocytes, as measured by expression of 2H4 
antigen which is considered a marker of Ts cells (McKay and Garnett, 1991).
A number of studies have implicated T lymphocytes as a potential site of latency. HCMV 
was found to persist in T lymphocytes stimulated by PHA or pretreated with 5-iodo-2'- 
deoxyuridine for a certain time post-challenge (St. Jeor and Weisser, 1977). Schrier et al 
(1985) detected HCMV IE RNA in a small number of T lymphocytes from the peripheral 
blood of healthy seropositive individuals. HCMV replication was found to occur in cells 
which had been adequately activated with IL-2 as evidenced by viral DNA synthesis using 
dot-blots and by late antigen synthesis using immunofluorescent studies and western blot 
analysis (Braun and Reisser, 1986). Later on, David et al (1987) isolated HCMV from the
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tonsil lymphocytes of four HCMV seropositive individuals from a total study group of 30 
patients. Accumulating evidence suggests that HCMV is able to infect T lymphocytes, and 
the extent of the infection is dependent on the strain of the virus and the subset of the T 
lymphocyte population.
ii) B lymphocytes
Production of antibody to HCMV could facilitate the clearance of virus both by 
neutralisation of circulating viral particles and by destruction of the virally infected cells by 
complement mediated lysis and antibody dependent cellular cytotoxity (ADCC) (Garnett, 
1986). A previous report suggested that a foetus was protected against the debilitating 
effects in utero of a CMV infection if maternal antibody was present (Stagno et al., 1982), 
but other conflicting data exist (Kinney, 1985). However passively transferred antiserum 
prevented symptomatic CMV associated interstitial pneumonitis in bone marrow transplant 
recipients (Winston et al., 1987) and in an experimental rat model where the animals were 
exposed to total body irradiation prior to rat CMV infection (Stals et a l , 1990). McKeating 
et al (1987) suggested that, by binding with a cellular protein p2 microglobulin (p2m), 
CMV is able to mask its important antigenic sites necessary for neutralisation. The p2in 
coated urinary CMV could not be neutralised by hyper-immune globulin, human immune 
sera or murine MoAb that could neutralise CMV growth in vitro. Neutralising secretory 
IgA antibodies have been identified both in cervical secretions and in saliva in humans, but 
in neither the cervix nor the mouth does their appearance or concentration correlate with 
cessation of viral excretion (Osbom, 1981). In the light of the above points and the fact that 
the spread of HCMV is predominantly through cellular inter-junctions, it is logical to 
question the protective role provided by CMV antiserum.
In HCMV infections, as in other viral infections, production of antibodies is almost a 
universal response to infection (Ho, 1982). But not all binding of antibodies and antigenic 
determinants of a virion are able to neutralise the infectivity of the virus. Only those
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antibodies which bind to specific epitopes with high avidity neutralise the virulence or 
cause effective immunoresponses against the virus infection (Mims and White, 1985). 
Non-neutralising antibodies may be responsible for some of the pathogenesis associated 
with virus infection (Garnett, 1986).
There is, at present, no convincing evidence to conclude the presence of HCMV in B 
lymphocytes except one report which showed that HCMV could persist in B lymphocytes 
(SB line) originating from a leukemia patient (Furukawa, 1979).
hi) Monocytes and macrophages
Human blood monocytes and their tissue counterparts, macrophages, are known to be multi­
functional cells responsible for many critical immuno-regulatory functions in the overall 
immune response. They range from antigen presentation (Rosenthal et al., 1980); 
production of a large number of biologically active molecules (Nathan et a l , 1980) which 
affect cell functions (Sorg et al., 1989); ADCC (Poplack et al., 1976) and direct tumoricidal 
activity (Le, 1983).
a) CMV infection of monocytes and macrophages 
Monocytes were initially suspected to be the target of HCMV infection (Onorato et al., 
1985; Forbes, 1989; Gem a et al., 1993; Soderberg et al., 1993). Double labelling 
immunofluorescence studies have suggested that the monocyte is particularly susceptible to 
HCMV infection in vitro (Rice et al., 1984). Early in vitro and in vivo data, mostly 
evidenced by IE and E antigens using indirect/direct immunofluorescence, showed that 
HCMV is capable of infecting monocytes and macrophages (Rice et al., 1984; Einhom et 
al., 1984; Wahren et al., 1986; Kapasi and Rice, 1986; Dudding and Garnett; 1987). 
Turtinen et al (1987) reported that HCMV DNA and EE RNA were predominantly detected 
in monocytes using in situ hybridisation to analyse HCMV-leucocyte interactions in 
imm unosuppressed individuals with persistent HCMV viremia. All these reports
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demonstrated that, under experiment conditions both in vitro and in vivo, HCM V infection 
of monocytes was restricted to early events in the replication cycle, resulting in a persistent 
or latent infection. However, Maciejewski et al (1993) demonstrated that freshly isolated 
monocytes can be infected with HCMV. The virus replication cycle in monocytes 
resembled that observed in fibroblasts but the virus yield was approximately 0.1 % of that 
observed in fibroblasts (Maciejewski et a l, 1993), and only a low percentage of monocytes 
appear to be infected. This percentage varying significantly depends on whether laboratory 
adapted or recent clinical isolates of HCMV were employed.
As an integral component of the cellular network, monocytes and macrophages function as 
phagocytic and secretory cells to mediate specific and nonspecific immune reactions. The 
essence of the multifunctional repertoire of monocytes and macrophages is their capacity to 
present antigen and deliver biologically active molecules to immune effector cells and to 
secrete cytokines that function directly as effector molecules. Thus they function as efficient 
and indispensable immune accessory cells.
Garnett (1981) has demonstrated that there is a change in the surface topography of infected 
monocytes as viewed by electron microscopy, with infected monocytes becoming rounded 
and losing microextensions such as microvilli. Dudding (1986) recorded that HCMV 
infection significantly reduced both adherence and spreading of peripheral blood 
monocytes. CMV infection suppressed the attendant respiratory burst/oxygen radical 
production as measured by a chemiluminescence assay and reduced monocyte phagocytic 
ability as measured by phagocytosis of radio-labelled erythrocytes (Kapasi and Rice, 1986). 
The latter may be due to a disruption of cytoskeletal elements (Dudding, 1986). Although, 
in a lymphocyte DNA stimulation assay, HCMV infection of monocytes does not appear to 
affect their ability to present HCMV antigen to T cells from seropositive donors (Wahren et 
al., 1986), the ability of these cells to present a range of other antigens (tetanus toxoid, etc.)
15
to autologous lymphocytes from seronegative donors were impaired (Buchmeier and 
Cooper, 1989).
Data from murine CMV models showed that macrophages infected with murine CMV 
remained adherent, and intact as indicated by negative trypan blue staining (Price et al., 
1987). Murine CMV (MCMV) infected murine peritoneal macrophages became enlarged 
and rounded with smooth surface countours; and transmission electron microscopy 
demonstrated various stages of viral maturation in the nucleus and cytoplasm (van Bruggen 
et al.y 1989). Intracellular organisation was generally retained, apart from the development 
of large, irregular, intra-cytoplasmic vacuoles, in which enveloped virions and cell debris 
accumulated (van Bruggen et al., 1989). Although cytophotometric analysis indicates that 
infected murine macrophages retained detectable levels of all phenotypic and functional 
markers, the loss of F4/80, Mac-1, FcR and the receptor for gluteralderhyde-fixed sheep 
blood cells were observed. An exception was H-2 expression, which was increased (Price 
et al., 1987). In MCMV infected murine macrophages phagocytic function, such as 
ingestion of colloidal gold or horseradish peroxidase (Hayashi et al., 1985), was decreased, 
which paralleled the loss of FcR expression. Although dehydrogenase and acid 
phosphatase activities were retained (Price et al., 1987), the levels of acid phosphatase 
activity and lymphocytostatic activity were decreased ( Van Bruggen et al., 1989). This 
decreased phagocytic function of monocytes and macrophages would impair their antigen 
presenting ability (Allen, 1987).
b) The role of monocytes and macrophages in HCMV infections 
Increasing evidence has implicated HCMV infected monocytes as an integral determinant in 
models of immunosuppression. Immunosuppression has been described in patients with 
HCMV mononucleosis as evidenced by decreased responses of peripheral blood 
lymphocytes to mitogenic stimulation (Rinaldo et al., 1980). Monocytes and macrophages 
were reported to be responsible for this defect (Carney and Hirschi, 1981), as monocytes
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taken from patients with HCMV mononucleosis suppress the proliferative response of 
normal lymphocytes to concanavalin A (Con A). Thus the immunosuppressive effect of 
HCMV on mitogen stimulated proliferation of lymphocytes depends on the presence of 
monocytes in the culture (Kapasi and Rice, 1986). The role played by monocytes and 
macrophages in immunosuppression is unclear. Virus challenge of monocytes could cause 
metabolic derangement and architecture changes in monocytes and macrophages, thus it 
would impairing cellular ability to both produce and respond to physiological mediators of 
the immune response, such as the decreased phagocytosis and altered production of IL-1 
and IL-1 inhibitor in HCMV infections (Moses and Garnett, 1990), resulting in 
immunosuppression or immunopathological effects on the human immune system.
Usually following a primary infection HCMV can remain latent. As described previously, 
HCMV replication is usually restricted at early steps of its replication cycle in monocytes 
and macrophages and thus it is possible that monocytes serve as a reservoir in HCMV 
dissemination and persistence (Garnett, 1986). Maciejewski et al (1993) observed that 
HCMV persisted in infected monocytes upon differentiation to macrophages, suggesting 
that monocytes may serve as a carrier of HCMV and a vector for viral dissemination. 
Evidence from murine CMV models demonstrated that when activated macrophages were 
obtained by intra-peritoneal injection of peptone into mice infected three months earlier with 
MCMV, MCMV was also recovered from these macrophages, but not from the 
lymphocytes (Hayashi et al., 1985).
Numerous activation and differentiation signals have been shown to abrogate latency of 
CMV. Human teratocarcinoma cells which are non-permissive for HCMV infection become 
permissive after being induced to differentiate by treatment with retinoic acid (RA) 
(Lafemina and Hayward, 1986). The change in the status of the teratocarcinoma cells for 
HCMV after differentiation bears at least a superficial resemblance to the situation of
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monocytes and macrophages in which differentiation of monocytes to macrophages leads to 
reactivation of latent infection (Lafemina and Hayward, 1986).
In monocytes and macrophages, blocks to progression of the lytic cycle could occur at any 
of the steps between adsorption and virion production, although restrictions at the IE 
transcriptional level and E post-transcriptional level are the only ones that have been 
reported in detail in peripheral blood monocytes (Lafemina and Hayward, 1988). A 
molecular block of CMV replication at the level of CMV mRNA transcription has been 
reported in murine macrophages (Dutko and Oldstone, 1981). Induction of macrophage 
phenotypes by pretreatment of ML-3 cells with phorbol ester, followed by HCMV 
challenge, resulted in a greatly extended period of expression of IL -lp  and TNF-a 
(Dudding et al., 1989). Phorbol ester induced differentiation also permits productive 
HCMV infection in a monocytic cell line (Weinschenker et al., 1987). Thus it is reasonable 
to accept the view that differentiating agents facilitate HCMV infection in monocytes and 
macrophages, as most viruses are dependent for their replication on cellular factors that may 
be limited to cells in a particular activation state or are expressed only in cells in a particular 
state of differentiation (Schmidt and Woodland, 1990). Thus activation or differentiation of 
cells may enhance virus replication.
iv) Bone marrow
Bone marrow is one of the two important central lymphoid tissues (the other is the thymus). 
Bone marrow consists of stromal elements. Stromal cells produce some crucial factors 
which are required in haematopoiesis. Viral infection of the stromal cells can result in 
altered production of some factors, thus affecting haematopoietic cell differentiation. 
Alternatively, viral infection of stem cells could directly affect cell proliferation and 
differentiation.
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A large body of evidence shows that HCMV infection following bone marrow 
transplantation is frequent (Neiman et al., 1973; Meyers et a l , 1975; Bechomer et al., 
1980; Cordonnier et al., 1983; Winston et al., 1984). A bone marrow biopsy performed to 
evaluate pancytopenia in a patient who had received a renal transplant, revealed large 
intranuclear inclusions diagnostic of HCMV (Penchansky and krause, 1979). Einhorn and 
Ost (1984) reported that human bone marrow leucocytes can express IE after exposure to 
HCMV in vitro. Crist et al (1977) found that the number of GM-CFUc generated from the 
bone marrow aspirates obtained from two infants with severe congenital HCMV infection 
increased, and serum derived from these patients stimulated a greater number of colonies 
than control serum. Mackintosh et al. (1993) demonstrated a suppression of normal 
haematopoiesis by HCMV in vitro both with the direct addition of HCMV to the culture 
plates as well as by the pre-incubation of bone marrow cells with HCMV followed by 
washing of the cells. This suppressive effect of HCMV on haematopoiesis may be 
mediated in part through T cells (Mackintosh et al., 1993). HCMV infection of either 
stromal cells or committed progenitor cells in the bone marrow has been found to affect the 
development of myeloid cells (Busch et al., 1991).
Some animal studies also suggest that CMV may be present in the bone marrow (Griffith et 
al., 1981; Bruggeman et al., 1985). Evidence from animal models implied that CMV 
infection of bone marrow could disturb the growth of bone marrow cells. Inoculation of 
murine bone marrow cultures with murine CMV resulted in a decrease in megakaryocytes 
and granulocytes (Petursson et al., 1984). Kramvis (1986) found that infection of passaged 
stromal cells of vervet monkey with vervet CMV resulted in the enhancement of colony 
stimulating activity by these cells.
1.1.7 HCMV infection as a cofactor in AIDS
At present, it is generally believed that HCMV infection is a marker for a third factor in 
AIDS. The possibility of HCMV infection as a cofactor for the development of AIDS may
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be considered from the point of view of theoretical justification and practical evidence. 
AIDS is a disease with very long incubation period. HCMV infection is 
immunosuppressive. Theoretically, it could facilitate the inception of HIV infection or 
accelerate its progression to AIDS. The reverse is not only possible but recognised, i.e., 
the facilitation of HCMV infection as a result of immunosuppression produced by HIV.
A number of possible mechanisms by which HCMV could enhance HIV replication are 
suggested: 1) HCMV antigen-presenting monocytes/macrophages may initiate the activation 
of T lymphocytes in which HIV replication is facilitated. 2) Cytokines produced by immune 
stimulation as a result of HCMV infection could activate HIV-infected cells. 3)HCMV may 
act by enhancing HIV viral DNA replication by transactivation (Yeung et al., 1993; Gozlan 
et al., 1993). 4) Synergistic infection of HCMV and HIV may occur in doubly infected 
cells.
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1.2 MONOCYTES AND MACROPHAGES
1.2.1 M yelopoiesis
Monocytes and macrophages are a type of mononuclear phagocyte derived from pluripotent 
haematopoietic stem cells in the bone marrow through a number of differentiation stages. 
The cells are generally classified as progenitors (i.e. granulocyte-macrophage colony 
forming unit), monoblasts and promonocytes in the bone marrow, monocytes in the 
peripheral blood and macrophages in various situations: lining the sinuses of the liver, 
spleen and other organs, and in tissue spaces. After a bone marrow transit time of about 6 
days, mature monocytes enter blood where they have a half life of about 3 days. During 
this process, the most obvious morphological change is the appearance of an indented, 
kidney shape nucleus in monocytes from the round nucleus in the promonocytes 
(Sundstrom and Nilssion, 1976). Cytobiochemical changes include increased release of 
lysosomal enzymes, increased cellular plasminogen activator activity, enhanced superoxide 
anion generation, and decreased 5-nucleotidase activity (Kelley et al., 1987). The cell 
surface expression of differentiation antigens changes during myelopoiesis (Cydyard and 
Grossi, 1990). CD 14 is induced on monocytes that cannot be detected on promonocytes 
(Howell et al, 1990). Although it is difficult to assess the functional potential of different 
stages of monocyte development, studies on myeloid tumour cell lines in vitro indicate that 
both phagocytic efficiency and Fc receptor (FcR) mediated cytotoxity are optimal in the 
mature cell (Cydyard and Grossi, 1990).
i) Proliferation and differentiation o f myeloid cells
Myelopoiesis follows a pattern of clonal proliferation through three successively larger 
classes of cells (Figure 2), which is common to all the eight blood-cell lineages (Metcalf, 
1989). Maturation proceeds in parallel with the final clonal proliferation, with the most 
mature cells, which enter the blood, being post mitotic and, to a great extent, incapable of 
further division.
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Figure 2  The hierarchy o f the haematopoietic population (M etcalf, 1989)
Haematopoietic stem cells
Differentiation Commitment
Committed progenitor cells
Further Differentiation Commitment
M orphologically identifiable immature cells
Maturation
M ature cells
ii) Molecular control o f cell division, differentiation and maturation in myeloid cells 
Myelopoiesis in vivo is tightly controlled by a group of glycoproteins, loosely termed as 
cytokines, through a uni-directional pathway from stem cells to monocytes and 
macrophages (Bass and Backner, 1991). There are very complicated interactions among 
these regulatory glycoproteins and some of them are described briefly in section 1.3. As it 
is unlikely that a proliferation inducer is also a differentiation inducer, the function of which 
is to stop cell proliferation in mature cells. However proliferation inducers are able to 
activate differentiation indirectly by inducing the production of differentiation inducers 
(Sachs, 1988). Hence proliferation and differentiation appear to be two distinct, but closely 
related facets of myelopoiesis.
1.2.2 The in v itro  study of m yelopoiesis
i) Myeloid cell culture
The accelerating development in tissue culture techniques and the exponential accumulation 
of the knowledge of the regulatory mechanisms involved in myelopoiesis have made
22
culturing myeloid cells in vitro possible. At present, all the human myeloid cells which can 
be maintained in vitro continuously are human leukemia cells (Collins et al., 1977), such as 
U-937, THP-1 and HL-60. The growth advantage that myeloid leukaemia cells have in 
vitro over normal cells is not their rapid growth rate, but their apparent inability to mature to 
functional, terminally differentiated end cells (Breitman et a l , 1983). This may result from 
a decreased ability to respond to exogenous differentiative factors or the occurrence of 
mutation in specific genes whose products are required for cell differentiation.
ii) Histocytic lymphoma cell line (U-937)
U-937, a human haematopoietic cell line, was derived from a previously healthy 37-year- 
old patient with a generalised histocytic lymphoma. The histocytic origin of the cell line 
was shown by its capacity for lysozyme production and the strong esterase activity (naphtol 
AS-D acetate esterase inhibited by NaF) of the cells (Sundstrom and Nilson, 1976). U-937 
cells have some macrophage characteristics including surface Fc and C3 receptors, the 
capacity for phagocytosis and ADCC (Koren et al., 1979). A small fraction of U-937 cells 
possess human leucocyte antigen (HLA) -DR and -DS/DC antigens, which are associated 
with macrophage accessory function in antigen specific T cell responses.
iii) Monocytic leukemia cell line (THP-1)
THP-1, a human leukemia cell line cultured from the blood of an 1-year-old boy with acute 
monocytic leukemia, was established by Tsuchiya et al (1980) a decade ago. This cell line 
has Fc and C3b receptors, but no surface or cytoplasmic immunoglobulins. The HLA 
haplotype of IH P -l was HLA-A2, -A9, -B5, -DRW1 and -DRW2. The monocytic nature 
of the cell line was characterised by the presence of a-napthyl butyrate esterase activity 
which could be inhibited by NaF, the production of lysozyme, the phagocytosis of latex 
particles and sensitised sheep erythrocytes and the ability to restore T lymphocyte response 
to Con A (Tsuchiya et a l ,  1980).
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iv) Promyelocytic leukaemia cell line (HL-60)
HL-60, the first human cell line with distinct myeloid features, was isolated from the blood 
of a patient with acute promyelocytic leukaemia. It proliferates continuously in suspension 
culture and consists predominantly of promyelocytes. HL-60 is induced to differentiate 
terminally to cells having many of the morphological features of mature granulocytes by 
exposure to a wide variety of compounds. These induced HL-60 cells have many of the 
functional characteristics of normal human peripheral blood granulocytes (Beritman et al., 
1983).
v) Retinoic acid induced differentiation o f U-937 and THP-1 cells
Myelopoiesis which is controlled by a group of cytokines through the pathway from stem 
cells to monocytes and macrophages in vivo (Bass and Beckner, 1991) can also be 
mimicked in vitro by using some chemical agents , such as 12-O-tetradecanoylphorbol 13- 
acetate ( T P A ), retinoic acid (RA) and vitamin D3 (Nakamura et al., 1986).
RA, a member of the retinoid family, has dramatic effects on the development and 
differentiation in a wide variety of systems in vivo and in vitro. The physiological 
concentration of RA is 10 nM. At the present time, the mechanism of the action of RA is 
not clear. A very speculative hypothesis for the mechanism is based on fatty acid activation 
and formation of fatty acyl-S-CoA (Breitman et al., 1983). In this model, there is a balance 
between the retinoylation and other modifications, such as phosphorylation, methylation, 
acetylation, occurring at the same site to which RA binds. When this other modification 
dominates, the cell continues to proliferate and does not differentiate, otherwise the cell 
enters differentiation.
RA may initially act at the cell membrane. A cellular RA binding protein is found in many 
tissues and may be important in the mechanism of RA action (Ong and Chytil, 1978; Stoner 
and Gudas, 1978; Shubeita et al., 1987). The mechanism whereby RA functions to
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regulate responses has been partly revealed by the discovery of a group of nuclear RA 
receptors, which seem to regulate gene expression by binding to cis-acting sequences and 
activating transcription, which is quite analogous to the mechanism of steroid and thyroid 
hormones (Petkovich et a l , 1988; Giguere et a l , 1989; Brend et al., 1988; Krust et a l,  
1989; Zelent et a l ,  1989; Bedo et a l ,  1989; Mangelsdorf et al., 1990). Corresponding 
DNA sequences associated with the regulation of the expression of RA induced genes have 
recently been defined (LoRosa and Gudas, 1988; Vasios et al., 1989).
RA is a very potent inducer of terminal differentiation of the human monoblast- and 
monocyte-like cell lines, U-937 and THP-1. Combined with other differentiation inducers, 
such as interferon-y (INF-y), RA at its physiological concentration can induce THP-1 cells 
to differentiate into mature cells with functions of macrophages (Hemmi et al., 1985). 
Functioning alone, RA can induce cell differentiation, but only at 10 times its physiological 
concentration (Nakamusa et a l, 1986). By incubation with RA, U-937 cells were shown to 
differentiate into monocyte-like cells characterised by increased hexose monophosphate 
shunt activity, phagocytosis and reduction of nitroblue tetrazolium (NBT) (Olsson and 
Breitman, 1982).
1.2.3 The effects o f virus infection on proliferation and differentiation of 
myeloid cells
Knowledge of the effects of viral infections on myelopoiesis comes predominantly from the 
in vitro studies of viral leukemogenesis, although viral leukemogenesis itself still remains 
one of the mysteries of virology and haematology (Baltimore, 1978). Murine leukaemia 
virus infection of myeloid cells alters the program of proliferation and differentiation (Teich, 
1978). Possibly the continued presentation of free virus, or cell surface viral glycoprotein, 
acts as a mitogenic signal to the productively infected cells in a mode of receptor-virus 
interaction and is the cause of cell neoplastic proliferation (McGrath and Weissman, 1978).
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HCMV infection stimulates cellular DNA synthesis and proliferation of quiescent fibroblast 
cells which are permissive for HCMV infection (Ho, 1991). Some rapid membrane- 
associated events are elicited by HCMV binding to its cellular receptor, and the occurrence 
of these phenomena are not dependent upon the infectivity of HCMV (Abubaker et al., 1990 
a and b). The molecular mechanism involved has been partly revealed by the finding that 
HCMV infection results in an increase in the transcriptional activity of cellular oncogenes of 
c-fos, c-jun and c-myc (Boldogh et al., 1991).
It remains uncertain as to whether HCMV affects the proliferation and differentiation of 
myeloid cells as the availability of the information regarding this respect is limited. As 
myeloid cells have been generally considered nonpermissive for HCMV infection, it is quite 
likely that the responses in HCMV infected myeloid cells may be totally different from those 
observed in productively infected fibroblasts. Numazaki et al (1993) reported that HCMV 
IEA, EA and LA were detected from both clinical isolate- and AD 169-inoculated U-937 
cells by flow cytometry. These U-937 cells proliferated as well as uninfected U-937 cells, 
but only a small number of AD169-inoculated U-937 cells survived after 14 days of 
inoculation. Sing et al (1993) demonstrated that HCMV inoculation of THP-1 cells failed 
to block cellular differentiation induced by RA or dimethyl sulfoxide.
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1.3 CYTOKINE PRODUCTION IN HCMV INFECTIONS
Proliferation and differentiation of mammalian cells are generally controlled by extracellular 
signalling factors, which are collectively called cytokines (Arai et al., 1990). They are 
actually a group of low m.w. (< 80 Kd) proteins which are normally glycosylated and are 
very important in intercellular communication, functioning in a paracrine or autocrine mode 
to mediate tissue (re)modelling and to orchestrate the activities of many types of cells in 
either physiological or pathological reactions with or without immune stresses. Production 
of soluble cytokines in response to viral infection is responsible for the sequelae in a number 
of viral infections (Garnett, 1986), such as the restricted replication of a number of viruses 
in phagocytic cells (Lopez-Guerrero et al., 1990). Since it is beyond the scope of this 
introduction to provide a comprehensive review of all cytokines, only selected cytokines that 
are mainly elaborated by monocytes and macrophages (e.g. IL-1, IL-6, tumour necrosis 
factor (TNF), interferon-y (IFN-y), granulocyte colony-stimulating factor (G-CSF) and 
granulocyte-macrophage-CSF (GM-CSF)) will be briefly covered.
1.3.1 Cytokines in context
A cytokine is defined as a soluble glycoprotein, non-immunoglobulin in nature, released by 
living cells of the host, which acts non-enzymatically in picomolar to nanomolar 
concentrations to regulate host cell functions (Nathan and Spom, 1991). Contrasting with 
the very simplicity of their definition, cytokines have an almost bewildering array of 
functions that involve almost all kinds of cells, inside and outside the haematopoietic system 
(Table 1) (Bussolino et al., 1989). In addition, the function that is manifested by a given 
cytokine can also be exerted by others. Most cytokines have the ability to promote and/or 
inhibit cellular proliferation and differentiation. Cytokines act as specialised symbols in a 
language of intercellular communication, alongside neurotransmitters, endocrine hormones 
and autacoids. However, they differ from the others in that the final effects of cytokines,
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i.e. acting as a positive signal or a negative signal, depend not only on the nature of the 
target cells, but also on the matrix in which the target cells exist (Nathan and Spom, 1991).
Table 1 Known haematopoietic growth factors and their target cells 
(Metcalf, 1989).
F a c t o r S y m b o l T a r g e t  ce lls
Granulocyte-macrophage G M - C S F M , G, eo, M eg, M ulti
colony-stimulating
factor
Granulocyte colony- G-CSF G, M
stimulating factor
Macrophage colony- M-CSF M, G
stimulating factor
M ultipotential colony- Multi-CSF, G, M, eo, m eg, mast,
stimulating factor IL-3 m ulti stem
Interleukin-1 IL-1 Stem
Interleukin-2 IL-2 T, B
Interleukin-4 IL-4 B, T, m ast
Interleukin-5 IL-5 B, eo
Interleukin-6 IL-6 B, T, G, m ulti
Leukaemia Inhibitor Factor LIF M
Tumour Necrosis Factor TNF T
Interferon IFN T, B, M, G
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1.3.2 Interleukin-1
IL-1 is a 17.5 Kd polypeptide immunoregulatory cytokine produced primarily by 
mononuclear phagocytes. Monocytes and macrophages are the primary source of IL-1 (IL­
l a  and IL -lp ) (di Giovine, 1990). The predominant form of IL -1  released upon 
stimulation of human monocytes and macrophages is IL-ip. Although IL-1 a  and IL -lp  are 
structurally different and are produced from separate genes on chromosome 2 in humans, 
both IL-1 a  and IL -lp  bind to the same IL-1 receptor, thus resulting in the same effects on 
their target cells.
IL-1 mediates tissue (re)modelhng, repair and inflammation by orchestrating the activities of 
many cell types (Dinarello, 1990). Its primary inflammatory function is through its 
induction of other inflammatory metabolites, such as prostaglandin E2, collagenase and 
phospholipase, thus acting as the endogenous pyrogen to cause fever and hepatocyte 
activating factor to stimulate liver cells to produce acute phase proteins. IL-1 is involved in 
both the beneficial and the destructive arms of the immune response to infections and 
injuries (Dinarello, 1989). An inappropriate secretion of IL-1 could result in profound 
tissue damage.
As a product of monocytes and macrophages, IL-1 plays a central role in the activation of T 
lymphocytes which are critically involved in inflammatory and immune responses 
(Hamblin, 1988). This function was initially observed by its thymocyte activating factor 
activity. In T cells activated by antigen via the T cell receptor it both induces the expression 
of IL-2 receptor and augments the production of IL-2 which is another essential element in 
lymphocyte activation. Depletion of IL-1 results in deficiency in lymphocyte proliferation. 
Although many of its effects are well documented, the molecular mechanism by which IL-1 
activates cells is not clear. Virtually all known signalling systems have been suggested and 
this area remains controversial (Mizel, 1990; O'Neill et al., 1990).
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1.3.3 C olony-stim ulating factors
The process of blood cell formation is sustained throughout life by a group of glycoprotein 
growth factors. These factors are known collectively as the colony-stimulating factors 
(CSF). The term derives from the observation that in vitro bone marrow culture CSFs 
share the capacity to stimulate colony formation of recognisable maturing cells from 
progenitor cells of different haematopoietic cell lineages (Siett, 1987).
There are a number of haematopoietic growth factors that are being extensively studied both 
in vitro and in clinical trials. These include granulocyte-macrophage colony-stimulating 
factor (GM-CSF); granulocyte colony-stimulating factor (G-CSF); macrophage colony- 
stimulating factor (M-CSF) and multi-colony-stimulating factor (Multi-CSF or EL-3).
GM-CSF, a 14 - 35 Kd glycoprotein produced by various cells, has growth enhancing 
effects on granulocyte, macrophage and eosinophil colonies. GM-CSF has the similar 
effects on mature cells in that it causes neutrophil and eosinophil activation and induces 
neutrophil phagocytosis. In clinical studies, GM-CSF treatment results in a dose- 
dependent, stable restoration of granulopoiesis in AIDS patients (Groopman, 1988).
G-CSF, a 19 - 20 Kd glycoprotein produced by macrophages and/or endothelial cells, 
stimulates mainly granulocytes, but may have indirect effects on other precursors when it is 
present in a high concentration.
M-CSF is a heavily glycosylated 47 - 76 Kd glycoprotein with the function to stimulate the 
growth of macrophage colonies and monocytic cell lines. It is a disulfide-linked dimer 
encoded by a single gene that gives rise to related forms of the molecule as a result of 
alternative RNA processing.
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IL-3 is a 20 - 25 Kd glycoprotein that is mainly derived from activated T cells and that 
supports the growth of virtually all types of haematopoietic progenitor cells, usually at 
several stages of their development. IL-3 has been reported to recruit GM-CSF responsive 
myelopoietic progenitor cells in aplastic anaemia (Herrmann et al., 1990).
CSFs have distinct receptors distributed on undifferentiated and mature cells of various 
lineages. However, since multi-CSF competes with the other CSFs and GM-CSF competes 
with G-CSF and M-CSF, it is apparent that CSFs with activity on multiple cells types bind 
to a number of cell lineage specific receptors.
1.3.4 Tumour necrosis factor and IL-6
Tumour necrosis factor-a (TNF-a) is a macrophage-derived TNF, while TNF-p is the T 
cell product. Although TN F-a and p have limited homology, they bind to the same 
receptor. Their genes are both located on chromosome 6 and mapped to MHC class III (Old, 
1987).
IL-6 is a 26 Kd protein initially isolated from T cells (or T cell hybridoma) with the activity 
to stimulate B cell growth and differentiation. The gene for IL-6 is located on chromosome 
7 in humans (Sehgal et al., 1986). The amino acid sequence and gene structure of IL-6 is 
similar to G-CSF. IL-6 has been shown to be a terminal differentiation factor that causes B 
cells to differentiate into plasma cells in the absence of proliferation. Its effects on cells 
probably depend somewhat on the pre-existing state of cell activation.
TN F-a and IL-6 share several biological properties with IL-1 (Table-2). In the process of 
antigen presentation TNF can synergise with IFN-y to induce MHC class II expression on 
THP-1 cells (Protillo et a l, 1989) and Ceuppens et al (1988) demonstrated that IL-6 acts as 
a co-factor with IL-1 to induce IL-2 production. The levels of TNF and IL-6 reported to 
occur during virus infections vary considerably (Dinarello, 1989). Some of the side effects
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attributed to IL-1 in viral infection can be produced by inappropriate secretion of these two 
cytokines (Dinarello, 1989).
1.3.5 Interferon
Monocytes and macrophages are one of the major sources of interferon (IFN). There are 
three antigenically and chemically distinct types of IFN, known as oc, P and y. The most 
important function of IFN recognised initially was its antiviral activity and the administration
Table 2 Com parison o f IL-1, TNF, and EL-6 (Dinarello, 1989)
Biological property IL-1 TNF IL-6
Endogenous pyrogen fever + + +
Hepatic acute-phase proteins + + +
T cell activation + +/- +
B cell activation + + /- +
B cell Ig synthesis + /- - +
Fibroblast proliferation + + -
Stem cell activation (Hemopoietin-1) + - +
Nonspecific resistance to infection + + +
Radio protection + + +/-
Synovial cell activation + + -
Endothelial cell activation + + -
Induction o f IL-1 and TNF from monocytes + + -
Induction o f IL-6 + + -
of exogenous IFN can inhibit the development of virus disease. Other studies using anti- 
IFN antibody to mouse IFN indicated that virally infected mice would have high mortality 
rates when they were treated with anti-IFN antibodies. Recently, IFN has been reported to 
protect the infected cells from an extensive blockade of host mRNA translation (Lopez- 
Guerrero et al., 1990). IFN induced an antiviral state in the host cells (Firedman and Vogel,
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1983). Although it was originally believed that IFNs have antiviral activity, the antiviral 
activity of IFN in the immune response has been shown to depend upon the timing and 
dosage (Mims and White, 1985). Excess interferon induced by localised viral infection may 
lead to the destruction of normal tissue (Garnett, 1986). In animal models, the 
administration of IFN to normal neonatal mice results in lesions in the kidney similar to that 
observed in lymphocytic choriomeningitis virus infection (Riviere et al., 1984). This 
feature may cause profound effects on the functions of helper T cells, thus altering the 
whole immune response against the virus.
IFNs are also involved in regulation of the immune response. IFN-y is atypical in that it is 
made only by lymphocytes and only following antigen-specific or non-specific stimulation 
and thus it can be regarded as a lymphokine with immunoregulatory functions (Mims and 
W hite, 1985). Some of its functions, as mentioned above are required to modulate the 
surface molecules on immunocomponent cells. IFN-y is also required in the development of 
Tc cells, especially during the early stages (Maraskovsky et al., 1989). Levin et al (1979) 
reported that there was an especially low lymphocyte response in patients with CMV 
mononucleosis, and at the same time the level of serum IFN was also very low. This 
contradicts the finding that CMV in vitro is able to stimulate T cells to produce IFN, 
including IFN-a, (3 and y, as reported by Griffiths (1987).
1.3.6 Inhibitor production and activity
The potent effects of a cytokine in vivo are strictly controlled so that its appropriate 
functions can then be performed. This is achieved at the level of either the cytokine 
production or the biological activity once the cytokine is produced. Although the best 
characterised regulation of cytokines is at the level of their synthesis, there are reports of 
production of inhibitors that can also regulate cytokine actions after cytokine synthesis.
i) The mechanisms o f inhibitor actions
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An inhibitor is theoretically able to act at several levels to ultimately eliminate the activities of 
a cytokine. It can affect the production and release of a cytokine; reduce the expression of 
the cytokine receptor; interact directly with the cytokine to inhibit the binding of the cytokine 
to its receptor, or alter the function of the receptor following binding of the cytokine. 
Considering the involvement of inhibitors, any observed proliferative activity of a culture 
supernatant revealed by a biological activity assay should always be regarded as a 
summation of inhibitory and stimulatory effects coexistent in the culture supernatant 
(Garnett, personal communication).
ii) Monocyte-macrophage derived inhibitors
The most extensively studied and, to a lesser extent, well characterised inhibitors produced 
by monocytes and macrophages are IL-1 inhibitors which are a heterogeneous group of 
molecules that inhibit one or more of the bioactivities of IL-1 (Larrick, 1989). IL-1 
inhibitors are cellular products produced by either normal or virally infected monocytes 
(Larrick, 1989). At present, both low (< 25 - 30 Kd) and high (> 95 Kd) m.w. IL-1 
inhibitors have been found.
Berman et al (1986) reported the production of a 9 Kd protein derived from a 24 hr 
monocyte culture. This factor inhibited IL-1 activity in the thymocyte co-mitogenesis assay, 
but had no effect on the proliferation of an IL-2 dependent cell line. An IL-1 inhibitory 
activity was also found in the medium conditioned by the monocytes grown on adherent 
immune complexes or Ig G (Arend et al., 1985; 1989). This protein only inhibited the 
proliferation of thymocytes either primed by IL-1 alone or IL-1 plus mitogens. From this 
monocyte conditioned medium, an IL-1 inhibitor was purified (Hannum et al., 1990). The 
purified protein bound to IL-1 receptor but had no IL-1 like activity, even at very high 
concentrations, and was therefore a pure receptor antagonist.
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A factor which inhibited the co-mitogenic activity of IL-1 on thymocytes, mitogen induced 
thym ocyte blastogenesis and IL-2 production by T lymphocyte was found in a 
lipopolysaccharide (LPS) stimulated human peripheral blood monocyte culture (Kashiwado, 
1989). The m.w. of this protein ranges from 130 - 150 Kd. This inhibitor suppressed the 
proliferative response of an IL-2 dependent cell line to exogenous IL-2 , but had no effect 
on IL-1 dependent proliferation, which suggested that, by interfering with the IL-2 
response, this inhibitor suppressed the biological activities of IL-1.
Goeken et al (1989) found a 60 - 70 Kd protein named as plasminogen activator inhibitor in 
a 6 day monocyte culture. As proteolytic cleavage of IL-1 is required for precursor IL-1 to 
become active, this plasminogen activator inhibitor may play a role in reducing the activity 
of IL-1.
in) Inhibitors from  monocytic U-937 and THP-1 cells
A number of inhibitory activities have been identified in the culture supernatants of both U- 
937 and THP-1 cell lines.
The U-937 cell line does not produce IL-1 as determined by the assay of mouse thymocyte 
proliferation (Fujiwra and Ellner, 1986). It spontaneously produces a suppressor factor 
which inhibits antigen and mitogen induced blastogenesis, subsequent IL-2 production and 
IL-2 receptor expression in T lymphocytes (Fujiwra et a l , 1987). Wilkins et al (1983) also 
demonstrated that U-937 cells stimulated with mitogen or lymphokines produces 
immunoregulatory factors which inhibit lymphocyte proliferation. From crude U-937 
culture supernatants, Sugimura et al (1989) purified a 45 - 67 Kd lymphocyte blastogenesis 
inhibitory factor that specifically inhibited IL-1 primed murine thymocyte proliferation by 
arresting PHA stimulated T cells at the early G1 phase of the cell cycle, but had no effect on 
IL-2 production and the expression of the 55 Kd component of the IL-2 receptor.
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THP-1  cells produce both IL-la and IL-lb as demonstrated by cell blotting assays (Gaffney 
et al.y 1989) and isoelectrofocusing assays (Tsai etaL, 1986) respectively. An inhibitor of 
the thymocyte response to IL-1 was possibly present in the crude conditioned medium and 
masked the expression of biologically active recombinant IL -la  (rIL -la ) and rIL-ip 
(Krauker, 1985; Gaffney e ta l.y 1989).
iv) Inhibitors from CMV-mfected monocytes-macrophages
Previous in vitro studies on monocytes and macrophages infected with HCMV revealed that 
the production of IL-1 was decreased. Turtinen et al (1989) demonstrated that there was no 
detectable IL-1 produced by THP-1 cells challenged with CMV until 24 hr p.i., while 
maximum amounts of TNF were detected in culture supernatants by 3 hr p.i., suggesting 
that TNF may play a role in IL -lp  induction. Further studies found that there was an 
increase in the production of IL-1 after CMV challenge of peripheral blood monocytes over 
a short period of time and the activity of supernatants harvested from challenged cells is 
always significantly greater than that of control cells (Moses and Garnett, 1990). Despite 
containing higher levels of IL-lp, supernatants from virus challenged cells were markedly 
less effective in supporting thymocyte proliferation. This was because an IL-1 inhibitor 
was concomitantly produced in higher amount by CMV infected monocytes and 
macrophages (Amento et al.y 1985; Moses and Garnett, 1990; Hannum et al.y 1990).
v) Inhibitors o f TNF-a
A  50 Kd inhibitor of TN F-a activity was isolated from the urine of febrile patients 
(Seckinger et al.y 1988). It competed with TNF-a at the level of receptor binding and was 
distinct from urine-derived IL-1 inhibitors.
Turtinen et al (1993) addition of lipopolysaccharide to cell cultures that had been infected 
with HCMV for 24 hours resulted in a significant reduction in released cytotoxic activity to 
mouse L929 cells at 3 - 22 hours post-lipopolysaccharide compared with mock-infected
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cultures. They, however, found that infected cultures had significantly high THF-a antigen 
levels that in mock-infected cultures using an ELISA to measure TNF-a antigen levels in 
these culture supernatants. This finding indicated that HCMV infection possibly induced the 
release of TNF-a inhibitor(s) which may have blocked TNF-a associated cytotoxic activity 
in HCMV-infected THP-1 cell culture supernatants.
vi) Inhibitors and the immune state
Although the functions of inhibitors produced in CMV infections have not been fully 
understood yet, it is likely that they will not be limited to inhibition of cytokine activities as 
described above. Studies on human immunodeficiency virus (HIV) and other viral 
infections in vitro have shown that low molecular weight IL-1 inhibitors impair the specific 
immune responses and promote polyclonal B lymphocyte activation. Lotz et al (1986) 
reported that a monocyte derived IL-1 inhibitor down-regulated the production of IL-2 and 
IN F-y by EBV infected peripheral blood mononuclear cells from both normal and 
rheumatoid arthritis individuals.
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1.4 AIMS OF THE STUDY
HCMV is a self-immunosuppressive pathogen which causes severe sequelae when the 
im m unity of the host is compromised, but frequently establishes latency in 
immunocompetent individuals. At the present time, available information suggests that 
HCMV infection of either progenitors in bone marrow or monocytes and macrophages in 
peripheral blood suppress the development of these cells. Also, human peripheral blood 
monocytes and tissue macrophages, which derive from the stem cells in bone marrow 
through myelopoiesis, may be a reservoir of latent HCMV infections. An activation or 
proliferation/differentiation of these cells may activate or enhance HCMV replication. 
However, the effect of HCMV infection on the cells undergoing proliferation/differentiation 
has not been addressed. The aim of this study was to answer to the question:
(1) How does HCMV infection affect the proliferation of promonocytes? Two 
promonocytic cell lines, U-937 and THP-1 which are representative of different phases of 
the developmental path were used in the present study.
Disturbed cytokine production of monocytes and macrophages in HCMV infections has 
been considered to be partly responsible for the suppressive functions observed in the cells, 
as accumulated evidence indicates that the frequency of HCMV infection in monocytes and 
macrophages is always extremely low. Information presented suggests that a shift in the 
balance of the production of inhibitors and stimulators by the infected cells may occur. 
With these pieces of information in mind, a further question has been addressed:
(2) Could HCMV infection affect the cytokine/inhibitor production by the cells 
which are undergoing proliferation/differentiation? With the availability of some chemicals 
(such as RA) which are able to inhibit proliferation and induce differentiation of 
promonocytes, it is possible to compare the influence of HCMV challenge on the inhibitor
39
production in the promonocyte stage with that in the monocyte-like stage along the 
myelopoiesis pathway.
It is hoped that an evaluation of the effects of HCMV challenge on promonocytes in vitro 
may contribute to an understanding of the interactions between promonocytes and HCMV in 
vivo.
Materials and Methods
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2.1 TISSUE CULTURE TECHNIQUES
2.1.1 Human foreskin fibroblasts
Human foreskin fibroblasts (HFFs) were grown as monolayers in plastic tissue culture 
flasks (Corning) in minimum essential medium (MEM, Cytosystems) supplemented with 
10% foetal calf serum (FCS, Commonwealth Serum Laboratories), 2 mM L-glutamine 
(Cytosystem s), 50 U/ml penicillin (Cytosystems) and 50 mg/ml streptomycin 
(Cytosystems). Cells were maintained at 37°C and separated when they were confluent 
using 0.25% trypsin-ethylenediaminetetraacetic acid. Fibroblasts used to prepare virus 
stocks of AD 169 were mycoplasma free as judged using 4'-6-diamidino-2 -phenylindole 
(DAPI) staining of DNA (Boehringer Mannheim GmbH). The passage number of the 
fibroblasts used in this study was between 7 and 20.
2.1.2 U-937 and THP-1 cell cultures
U-937 and THP-1 cells were continuously grown in suspension in 25 cm2 plastic tissue 
culture flasks (Coming) in R P M I1640 medium (Flow) supplemented with 10% FCS, 2mM 
L-glutamine, 50 U/ml penicillin and 50 mg/ml streptomycin at 37 °C in 5% CO2. Cells 
were refed every 48 hr. Cell density was maintained at approximately 1 - 5 x 105 cells/ml 
for both cell lines by dividing one flask of cells into two or three flasks. Aliquots of cell 
suspensions were counted with the aid of a hemocytometer using trypan blue exclusion. 
The U-937 and THP-1 cells used in these experiments were mycoplasma free as judged 
using DAPI stain.
2.1.3 Trypan Blue Exclusion
0.5 g trypan blue powder (ICN) was dissolved in 100 ml PBS (pH 7.4). A cell suspension 
in PBS containing approx. 5 x 10^ cells/ml was prepared. 500 pi cell suspension was then 
mixed with 500 pi trypan blue solution. Viable cell number was then counted on a
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hemocytometer under a light microscope. Blue stained cells were excluded from the 
counting. Viable cells per ml and total viable cells were calculated as follow:
CELLS/ML = the average count per square x dilution factor x 104 (count 10 squares). 
TOTAL CELLS = cells/ml x the original volume of fluid from which cell sample was 
removed.
2.1.4 DAPI stain
2.5 mg/ml DAPI (Sigma) stock solution was prepared by dissolving DAPI crystals in glass 
distilled water. 0.2 ml of the stock solution was diluted to 10 ml with absolute methanol to a 
final concentration of 45 to 50 mg/ml. Cells were spun down by low speed centrifugation 
(435g for 5 minutes) and washed once with Hank's solution (Appendix). These cells were 
then resuspended in DAPI-methanol solution and incubated for 10 - 30 minutes at 37 °C. 
One drop of the incubation mixture was placed on a microscope slide, dried at room 
temperature and viewed under a fluorescent microscope. A 340/380 nm excitation filter and 
LP430 nm bander filter magnification was generally sufficient in detecting brightly 
fluorescent mycoplasmas. Best results were obtained using a 100 x oil immersion objective.
2.1.5 Retinoic acid treatment
RA (C20H28O2, type XX) was purchased from Sigma chemical Co. (St. Louis, MO.). By 
dissolving 3 mg RA in 10 ml 96% ethanol, a 1 mM stock solution was prepared and it was 
stored in the dark at -20^C. To gain the required working concentrations of RA as indicated 
in the corresponding experiments, an appropriate volume of stock solution was added 
directly to the medium in which cells were to be cultured when the medium was replaced.
2.1.6 Tritiated thymidine incorporation
Aliquots of cell suspensions were taken every 24 hr when medium was replaced, and 
incubated in a round bottom 96-well Nunc plate (200 (il/well) at 37°C in a 5% CO2 
atmosphere. Tritiated thymidine ([^H]TdR: 0.5 pCi/well. Amersham) was added into each
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well at the beginning of the incubation period. After 1 hr incubation for U-937 and 24 hr 
incubation for THP-1 cells, cells were harvested using a Titertek multiwell harvester (Flow) 
and [3H]TdR incorporation measured using 5ml of an aqueous scintillant (ACS, 
Amersham). The cell proliferation was determined as the mean ± standard deviation (SD) of 
the incorporated of [3H]TdR in counts per minute (CPM) for triplicate samples.
2.2 HUMAN CYTOMEGALOVIRUS AD169
2.2.1 HCMV AD169
The laboratory adapted HCMV strain AD 169 was propagated in mycoplasma free HFF 
grown at 37 °C in MEM supplemented with 1% FCS. Cells and supernatants were 
harvested when the CPE was well advanced. Intracellular and cell associated virus was 
released by freeze-thawing twice and cell debris then removed by a low speed centrifugation 
(435 g for 5 minutes). An equal volume of FCS (in a final concentration of 50 % v/v) or 
70% sorbitol (in a final concentration of 35% w/v) was added to the supernatant fluid and 
virus stocks were stored at -80°C.
2.2.2 Virus titration
HFF were seeded at a confluency of 70% on a 96-well microtitre plate (Nunc). After 24 hr, 
cells were washed once with Hanks Balanced Salt Solution (HBSS), then serial 10-fold 
dilutions of virus were adsorbed to the cells. After a 90 minute incubation period, viral 
inocula were removed and cells were maintained in MEM containing 1% FCS for 10 days 
with the medium being changed every 48 hr. After 10 days, the medium was removed and 
cells were washed once in HBSS. Quick Dip Staining (Histo-labs) was used to visualize 
viral CPE. The tissue culture infectious dose fifty (TCID50) was taken as the highest 
dilution which gives an observable cytopathic effect in 50% of the wells. The virus titre, 
plaque forming units per ml (PFU/ml) was expressed in mean tissue culture infective dose 
(TCID 50) per ml. The titre of the virus stock used was around 5 x 106 PFU/ml in all
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experiments. The actual end point dilution (giving 50% end point) can be calculated using
the ration: ______ % infection next above 50% -50%_______________
% infection next above 50% - % infection next below 50%
2.2.3 Ultraviolet irradiation of virus stocks
A 1 ml sample of HCMV AD 169 stock was inactivated by periodic agitation in a 35 mm 
plastic plate (Corning) with a Oliphant daul-wave model (SLM6) ultraviolet (UV) 
transilluminator (G6T15N) at 254 nm wavelength at a distance of 5 cm which produced 720 
ergs/sec./mm^ at the surface of the plate for 15 minutes. The front glass of the UV lamp 
was taken off and the plate was uncovered and placed on ice to prevent any increase in 
temperature (< 5 at the bottom of the plate) of the virus stock during irradiation. Virus 
inactivation was determined by comparison of the titers of irradiated (0 PFU/ml) and 
nonirradiated virus (5 x 106 PFU/ml). All equipment used in this procedure was previously 
sterilised with 70 % ethanol and the virus inactivation was conducted in a biologic safety 
cabinet with air flow on.
2.2.4 Virus challenge of U-937 and THP-1
Mycoplasma free U-937 and THP-1 cells were washed once with RPMI 1640 medium, then 
inoculated with infectious or UV-inactivated HCMV AD 169 suspensions diluted in 5.0 ml 
RPMI 1640 medium to give an multiplicity of infection (m.o.i) of 1 or 5. Controls were set 
up by either (a) challenging the cells with supernatant from which the virus had been 
removed by centrifugation at 60,000 rpm in Beckman Ti 75 rotor on Sorvall OTD-65 
centrifuge for 8 hrs (the supernatant was harvested from the AD 169 infected HFF culture at 
the same time the virus stocks were prepared) or (b) treating the cells with RPMI 1640 
medium. After incubation at 37 °C for 90 minutes, the inoculum was removed by a low 
speed centrifugation (220 g 5 minutes for U-937; 435 g 5 minutes for THP-1). Infected 
cells were maintained in RPMI 1640 containing 10% FCS at 37 °C in a humidified 5% CO2 
atmosphere. Whenever required, aliquots of cell suspenions were removed after which cells
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were pelleted by low speed centrifugation (435 g for 5 minutes) and resuspended in fresh 
medium. The supernatant was recovered from the collected culture medium by 
centrifugation at 26,000 tpm in Beckman Ti 75 rotor on Sorvall OTD-65 centrifuge for 60 
minutes and was stored at -70^C for the following experiments
2.3 INHIBITOR ASSAY
The biological activity of the supernatants was assessed by using a modified standard 
thymocyte co-mitogenic assay. Thymocytes were obtained from 6 - 8 week (wk) old 
BALB/c mice scarified by cervical dislocation. A thymus was teased apart with sterile 
forceps into HBSS. Tissue pieces were sedimented by gravity and cell aggregates removed 
by passage of the cell suspension through a stainless steel mesh. The resulting single cell 
suspension was pelleted by centrifugation (400g for 4 minutes), rinsed two times in HBSS 
and resuspended in RPMI supplemented with 10% FCS, 2mM L-glutamine. The viability 
of the thymocytes isolated in this manner was between 97% to 100% using trypan blue 
exclusion. Thymocytes were then incubated in round bottom 96-well microtitre plates 
(Nunc) in RPMI 1640 medium supplemented with PHA (lpg/m l, Wellcome) and human 
recombinant IL-2 (rIL-2: 2 U/ml, Boehringer Mannheim GmbH). Monocyte supernatants 
were used at 10% and 20% (v/v) in a final volume of 250 pl/well. Thymocyte proliferation 
was assessed by measuring the uptake of [3H]TdR (0.5 |LiCi/well. Amersham) over the last 
24 hr of the 72 hr period at 37 °C in a 5% CO2 incubator. Cells were harvested onto a glass 
fibre filter using a Titertek multi well harvester (Flow) and [3H]TdR incorporation measured 
using 5ml aqueous scintillation fluid (ACS, Amersham). The supernatant activity was 
determined as the mean ± SD of the incorporation of [3H]TdR in CPM for triplicate 
samples. Data were analysed using one factor Anova test.
2.4 NITROBLUE TETRAZOLIUM REDUCTION
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Tetradecanoylphorbol acetate was freshly diluted in phosphate-buffered saline (PBS) to a 
final concentration of 200 ng/ml. 0.02 g nitroblue tetrazolium (NBT) was then dissolved in 
10 ml of PBS - tetradecanoylphorbol acetate solution. Cells (5 x 105 cells/ml of medium) 
were incubated for 25 min at 37°C with an equal volume of the NBT solution The 
percentage of cells containing intracellular blue-black formazan deposits was then 
determined on Wright-Giemsa-stained Cytospin slide preparations. Cytospin slides were 
prepared using Shandon Cytospin Centrifuge. At least 200 cells were assessed.
Jesuits
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3.1 T H E  E FF E C T S O F HCM V CH A LLEN G E ON TH E  PR O L IF E R A T IO N  
O F PR O M O N O C Y TIC  CELLS U-937 AND THP-1
Cell proliferation results in an increase in the cell number with a corresponding increase in 
the total amount of DNA in the population of cells. On the other hand, the cell number and 
the amount of DNA remain stable when the population of cells enter differentiation. Thus, 
by counting the viable cell number and measuring the total amount of radioactively labelled 
DNA, by incorporation of [3H]TdR, the extent of cell proliferation can be followed. In 
combination with cyto-biochemical study to ensure morphological alterations, the extent of 
cell proliferation/differentiation can be determined.
3.1.1 The p ro life ra tion  of the prom onocytic cells U-937 and THP-1
U-937 and THP-1 cells were seeded at a density of 2 x 105 cells/ml in complete R P M I1640 
medium and grown for 6 days. Every 24 hr haemocytometer counts were performed on 
aliquots of the cell suspensions using Trypan Blue Exclusion. The medium was then 
completely replaced by the same volume of fresh medium. No trypan blue positive cells 
were observed over the 6 day culture period. Viable cell number of both cell lines increased 
with time, with exponential growth occurred at 48 hr after initiation of the culture (Figure 3). 
U-937 cells proliferated faster than did THP-1 cells. In THP-1 cell cultures, cells grew as 
loose clumps which could be disrupted by a gentle agitation. The results presented in Figure 
3 were from one representative experiment in which cell counts were performed three times 
for each cell line at each time point. Similar results were obtained in two experiments.
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Figure 3 The proliferation of U-937 and THP-1 cells U-937 and 
THP-1 ceils were cultured in complete RPMI 1640 medium for 6 days. Every 24 hr 
viable cell counts were performed on aliquots of cell suspensions by using trypan 
blue exclusion and then the medium was replaced. Data from one representative 
experiment was plotted as viable cell number over time, each point being the average 
of three counts for each cell line.
Time (hr)
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3.1 .2  The effects o f 35% sorbitol preserved HCMV challenge on the 
proliferation o f THP-1 cells
As a routine method in this laboratory, HCMV AD 169 was stored in a final concentration of 
35% w/v sorbitol at -80°C. However, it was important to ascertain whether sorbitol affect 
the cell proliferation of promonocytic cells before using such virus stocks. Considering the 
dilution of virus stocks which would be added to cell cultures, the same concentration of 
sorbitol to which the cell lines would be exposed was calculated as 3% w/v. Thus in the 
preliminary experiment, THP-1 cells were treated with 1) RPMI 1640 medium; 2) 
uninfected human foreskin fibroblast (HFF) culture supernatant; 3) uninfected HFF culture 
supernatant plus 3% w/v sorbitol; 4) HCMV infected HFF culture supernatant with virus 
removed by ultra-centrifugation, but containing 3% w/v sorbitol; 5) MEM medium plus 3% 
w/v sorbitol (as HFF was originally cultured in MEM medium); 6) HCMV AD 169 
suspension containing 3% w/v sorbitol.
As shown in Figure 4, THP-1 cells treated with 3% w/v sorbitol, regardless of the presence 
of HCMV, exhibited a decreased viability at 12 - 24 hr after the treatment. THP-1 cells 
treated with HCMV plus 3% w/v sorbitol did not recover from the decreased proliferation 
after a 72 hr culture, while recovery was observed where cells were exposed to various 
other media containing 3% w/v sorbitol. These results suggest that 3% w/v sorbitol does 
affect the viability of THP-1 cells and that the presence of HCMV exacerbates this effect
Hence, in the following experiments, all the virus stocks were prepared in 50% v/v foetal 
calf serum (FCS), stored at -80°C and used immediately after thawing.
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Figure 4 The e ffects  of sorb ito l on the v iab il i ty  of THP-1 cell
THP-1 cells of a density of 0.9 x 106 cells/ml were challenged with 35% sorbitol 
preserved HCMV AD 169 (5 x 107 pfu/ml) at a m.o.i. of 5 in a final volume of 5 ml. 
The final concentration of sorbitol was 3% w/v. Controls were set up as indicated. 
Viruses were allowed to adsorb to cells at 37°C in 5% CO2 for 90 min with gentle 
mixing every 10 min. Cells were then separated from non absorbed virus by low 
speed centrifugation and resuspended in RPMI 1640 medium containing 10% FCS, 
2mM L-glutamine, 50 U/ml penicillin and 50 mg/ml streptomycin. Using trypan 
blue exclusion, the viable cell number was counted in aliquots of cell suspensions at 
12 hr, 24 hr, 48 hr and 72 hr. Data were plotted as mean ± SD where three aliquots 
of cells in each treatment were counted at each time point.
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3.1.3 The effects o f HCMV challenge on the proliferation of THP-1 cells
Promonocytic THP-1 cells were challenged with infectious HCMV and UV-inactivated 
HCMV at m.o.i of 1 and 5. As the virus was originally produced in HFF cultures as 
described in Section 2.2.1, to exclude the possible effects of factors produced by the HFF 
cells either spontaneously or due to the virus infection, 3 different controls were set up. 
THP-1 cells were cultured in the growth medium containing 1) RPMI 1640 medium 
(control); 2) HFF culture supernatant (HFF SN); 3) supernatant harvested from HCMV 
infected HFF cultures with the virus removed by high speed centrifugation (V spun-out 
HFF SN). The V spun-out HFF SN was tested in routine TCID50 assays to determine its 
infectivity before added to THP-1 cultures. No CPE was observed, even when undiluted V 
spun-out HFF SN was added to HFF cells, suggesting that no detectable level of infective 
virus was left in the virus-cleared supernatants.
As shown in Figure 5, THP-1 cells treated with HFF SN and V spun-out HFF SN showed 
a growth pattern similar to that of the cells treated with RPMI 1640 medium, suggesting that 
no soluble factors was produced by HCMV-infected HFF cultures, which would affect the 
proliferation of the THP-1 cells. However, both THP-1 cultures challenged with either 
HCMV or UV-inactivated HCMV demonstrated a reduction in viable cell number. A drop 
of about 65% in viable cell counts was seen during the first 24 hr, which was then followed 
by a gradually increase in viable cell counts. After 96 hr, virus-challenged cells showed a 
similar, but slightly lower proliferation when compared with that of unchallenged cells. 
Concomitant with the drop in viable cell counts was the appearance of large amounts of cell 
debris and trypan blue positive cells in both cultures at 24 hr post-challenge. Similar 
phenomenon was also observed when the experiment was repeated with a virus/cell ratio 
(m.o.i.) of 1 .
Consistent results were obtained by a determination of the cell proliferation by measuring 
[3H]TdR incorporation in virus-challenged THP-1 cells. The experiment was performed
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under conditions as described in section 2.1.4. As shown in Figure 6, a marked drop in the 
uptake of [3H]TdR was observed in virus-challenged THP-1 cells at 24 hr post-challenge, 
which was followed by a gradual increase in [3H]TdR incorporation. A reduction in viable 
cells over the first 24 hr period of post-challenge was very likely responsible for the 
decreased uptake of [3H]TdR in the virus-challenged THP-1 cell cultures.
The observed cell debris and trypan blue positive cells at 24 hr post-challenge may partly 
have resulted from unrecoverable cell membrane damage as a consequence of the 
interactions between the virus and cell. If this was the case, damaged cells should be 
visualised by positive staining with trypan blue immediately after the completion of the co­
incubation of cells and virus, and this effect would be very likely virus-dose dependent. As 
shown in Table 3, viable cell counts showed no obvious change after THP-1 cells were co­
incubated with HCMV at a m.o.i. of 1 for 90 min. However, when the m.o.i. was 
increased to 5, viable cell counts dropped 10% in THP-1 cells challenged with UV- 
inactivated HCMV and 14% in cells challenged with infectious HCMV, suggesting that 
some alterations of the cell membrane were induced by the interactions between the virus 
and THP-1 cells and the consequence of the interaction was virus-dose dependent.
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Figure 5 The effects of HCMV challenge on the proliferation 
of THP-1 cells THP-1 cells were challenged with HCMV AD 169 at 
m.o.i of 5. By using trypan blue exclusion, daily haemocytometer counts 
were done on three aliquots of cell suspensions for each treatment. This 
experiment was repeated at a m.o.i. of 1 and a similar pattern of results were 
observed. Cells challenged with infectious or UV inactivated HCMV 
proliferated more slowly than did unchallenged cells in the first 72 hours after 
the virus challenge.
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Figure 6 The effects of HCMV challenge on [3 H ]TdR  in co rp o ra t io n  
of THP-1 cells THP-1 cells were challenged with HCMV and UV-inactivated 
HCMV at a m.o.i. of 5. After 90 min incubation, cells were separated from non 
absorbed virus by low speed centrifugation and resuspended in complete RPMI 
1640 medium. Every 24 hr after the medium was fully replaced, aliquots of cell 
suspensions were taken and incubated with [3H]TdR (0.5 pCi/well ) in a round 
bottom 96-well plate at 37 °C in 5% CO2 for 1 hr. Cell proliferation was 
determined as the mean ± SD of the incorporation of [3H]TdR cpm for triplicates 
of each treatment. This experiment was repeated at a m.o.i. of 1 and similar 
pattern of results were obtained.
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Table 3 The viability of HCMV challenged THP-1 cells
THP-1  cells were pooled at a cell density of 8.6 ± 0.5 x 105 cells/ml in RPMI 
1640 medium and aliquoted into 25 cm2 Corning tissue culture flasks. 
Suspensions of HCMV and UV-inactivated HCMV were added to a dilution 
of m.o.i of 1 or 5. The final volume of each flask was 5 ml. Virus was 
allowed to adsorb to cells at 37°C in 5% CO2 for 90 min with gentle mixing 
every 10 min. Cells were then separated from non adsorbed viruses by low 
speed centrifugation and were resuspended in same volume of RPMI 1640 
medium. Control cells were treated with the supernatants from uninfected 
HFF. Using trypan blue exclusion, viable cell number was counted in 
aliquots of the cell suspensions at the end of the 90 minute incubation. The 
data was mean ± SD of values from two experiments where three aliquots of 
cells for each treatment were counted.
Viable cell count (x 10^ cells/m l)
Sam ples Before viral infection 90 min postinfection
Control 8.6 ±  0.5 8.5 ± 0.6
Exp. 1 UV-Adl69 
M OI = 1 8.6 ± 0.5 8.7 ± 0.3
AD 169 
M OI = 1 8.6 ±  0.5 8.1 ±  0.9
Exp. 2 UV-AD160 
M OI = 5 8.6 ±  0.5 7.7 ± 0.2*
AD 169 
M OI = 5 8.6 ± 0.5 7.4 ± 0.2#
* Viable cell count dropped by 10%.
# Viable cell count dropped by 14%.
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3.1.4 The effects of HCMV challenge on the proliferation o f U-937 cells
To study the effects of HCMV AD 169 challenge on the cell proliferation, U-937 cells were 
challenged with HCMV and UV-inactivated HCMV at a m.o.i. of 5 under the conditions as 
described previously for the study of the effects of HCMV challenge on the proliferation of 
THP-1 cells (Section 3.1.3). Viable cell counts showed a gradual increase in both virus- 
challenged and unchallenged cultures (Figure 7). The cells challenged with HCMV and 
UV-inactivated HCMV showed a suppressed proliferation for the first 72 hr after the 
initiation of the challenge.
A [3H]TdR incorporation assay was also used to measure the level of [3H]TdR uptake in 
virus-challenged cells under the conditions described in Section 2.1.4. In U-937 cells 
which were challenged with HCMV and UV-inactivated HCMV, [3H]TdR uptake was 
apparently decreased over the first 96 hr after the initiation of the culture (Figure 8).
Taken together, these results suggest that interactions between virus and U-937 cells may 
negatively affect the cell metabolism which is responsible for cellular DNA synthesis and 
cell proliferation.
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Figure 7 The effects of HCMV challenge on the proliferation of U 
937 cells U-937 cells were co-incubated with HCMV and UV-inactivated HCMV 
at a m.o.i. of 5 for 90 min. After removing non absorbed virus, cells were 
resuspended in complete RPMI 1640 medium. Every 24 hr, viable cell counts were 
performed on three aliquots of cell suspensions for each treatment before the medium 
was fully replaced. Data were plotted as mean ± SD of values from one 
representative experiment. Similar trends were obtained when this experiment was 
repeated at a m.o.i. of 1.
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Figure 8 The effects of HCMV challenge on [3 H ]TdR  in c o rp o ra t io i  
of U-937 cells U-937 cells were challenged with HCMV and UV-inactivated 
HCMV at a m.o.i. of 5. After 90 min incubation, cells were separated from non 
absorbed virus by low speed centrifugation and resuspended in complete RPMI 
1640 medium. Every 24 hr after the medium was fully replaced, aliquots of cell 
suspensions were taken and incubated with [3H]TdR (0.5 pCi/well ) in a round 
bottom 96-well plate at 37 °C in 5% CO2 for 1 hr. Cell proliferation was determined 
as the mean ± SD of the incorporation of [3H]TdR cpm for triplicates of each 
treatment. This experiment was repeated at a m.o.i. of 1 and similar trends were 
obtained.
Time (hr)
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3.2 THE EFFECTS OF HCMV CHALLENGE ON THE PROLIFERATION  
OF U-937 AND THP-1 CELLS IN THE PRESENCE OF RETINOIC ACID
Retinoic acid (RA) was used to inhibit proliferation and to induce differentiation of U-937 
and THP-1 cells. Previously reported data suggested that a RA concentration of 500 nM 
and a treatment of 6 days were necessary to inhibit cell proliferation and to induce the cells to 
enter differentiation (Hemmi et al.y 1985; Nakamura etal., 1986).
3.2.1 The effects o f ethanol on the cell proliferation
As ethanol was required as a solvent to dissolve RA prior to use (Section 2.1.3), it is 
important to know the possible effects of ethanol on the proliferation and differentiation of 
U-937 and THP-1 cells. Both cell lines were cultured in complete RPMI 1640 medium 
containing ethanol which was diluted 2000 times from a 96% stock (i.e. the concentration is 
equivalent to that used in the 500 nM RA). Aliquots of cell suspensions were counted every 
24 hr using the method of Trypan Blue Exclusion. Trypan blue positive cells accounted for 
less than 3% of the total cell number. There was no difference in viable cell counts between 
ethanol-treated and untreated cells over the 6 day period of the cell culture (Figure 9). After 
completion of the culture, Quick-Dip stained Cytospin slide preparations were prepared. No 
morphological differences were observed between cells of ethanol-treated and untreated 
cultures.
3.2.2 The effects of retinoic acid on the cell proliferation
When cultured in the medium containing 500 nM RA as described in the legend of figure 10, 
the proliferation of U-937 cells was greatly inhibited (Figure 10). This decreased 
proliferation did not result from cell death, as no trypan blue positive cells were observed 
over the time period of the culture. Furthermore, when the cells initially cultured in the 
medium containing 500 nM RA were transferred to fresh medium without RA, they showed 
a rehabilitated proliferation similar to that of the cells which were continually maintained in
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the medium without RA (Figure 10, Sample 1). In contrast, there was only a low increment 
in the cell number for the cells which were continually kept in the medium containing 500 
nM RA (Figure 10, Sample 2)
The inhibitory effect of RA on cell proliferation was also studied by measuring [3H]TdR 
incorporation in U-937 cells under the conditions as described in the legend of Figure 1 1 . 
The peak level of [3H]TdR uptake of U-937 cells cultured in the absence of RA appeared at 
72 hr after initiation of the culture, which was followed by a slightly decrease, but stable 
level of [3H]TdR incorporation over the rest of the time period of the culture. In the 
presence of 500 nM RA, [3H]TdR incorporation of U-937 cells remained at an apparently 
low level. This low level of [3H]TdR uptake indicated that a small proportion of U-937 
cells which were not very sensitive to (500 nM) RA continued their proliferation. This 
proportion of cells may have been responsible for the increased proliferation after RA was 
withdrawn from cultures as previously described.
Taken together, these results indicated that RA markedly inhibited the proliferation of U-937 
cells under the present conditions. However this inhibition was reversible when RA was 
withdrawn.
Morphological alterations were visualised in 40 - 50% of RA-treated U-937 cells on Diff- 
Quick (Lab Aids) stained Cytospin slide preparations (Figure 12). The most obvious 
alterations were the appearance of an indented, kidney shaped nucleus, and a decrease in the 
nuclear/cytoplasm ratio. Cells with these changes were also slightly bigger than the RA 
untreated cells. About 10% of the total cell number of the RA-treated cells attached to the 
flask surface. None of these changes could be observed in the cells which were maintained
in the medium without RA.
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Similar results were also obtained from THP-1 cells which were treated with RA under the 
conditions as described above for U-937 cell cultures (Figure 13). However, no apparent 
morphological alterations were observed in RA-treated THP-1 cells of which about 3% 
stuck to the flask surface over an 8 day cell culture .
Concomitant with the RA-associated suppression of cell proliferation for both cell lines and 
the morphologic alterations in U-937 cells was a time-dependent increase in the percentage 
of cells reducing NBT (Figure 14). At day 6, 45% THP-1 and 85% U-937 cells induced by 
500 nM RA were able to reduce NBT. Viability of both cell lines cultured with 500 nM RA 
for 6 days was approximately 95% , indicating that the increase in differentiation did not 
result from an enrichment of spontaneously differentiated cells in cultures.
Figure 9 The effects of ethanol on the proliferation of U-937 and 
THP-1 cells U-937 (a) and THP-1 (b) cells were cultured in complete RPMI 1640 
media without or with ethanol which was 2000 times diluted from a 96% stock . Data 
were plotted as mean ± SD of values from one representative experiment for each cell 
line. Three aliqoutes of cells were counted at each time point. Within each cell line, no 
observable difference in the viable cell number can be seen between ethanol treated and 
untreated cells over a period of 6 days.
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Figure 10 The effects of RA on the proliferation of U-937 celh
U-937 cells were seeded at a density of 5 x 105 cells/ml in complete RPMI 1640 
medium without (Control) or with 500 nM RA (Samples 1 and 2). Every 24 hr, 
using trypan blue exclusion, viable cell counts were performed on aliquots of cell 
suspensions and the medium was then fully replaced. 72 hr after initiation of the 
culture, RA was withdrawn from the medium of U-937 cells in Sample 1. Data 
were plotted as mean ± SD of values from one representative experiment where three 
aliquots of cells in each treatment were counted at each time point.
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Figure 11 The effects of RA on [^HJTdR incorporation of U-93 
cells U-937 cells were seeded at a density of 5 x 105 cells/ml in complete RPMI 
1640 medium. Every 24 hr after the medium was fully replaced and aliquots of cell 
suspensions were taken and incubated with [3H]TdR (0.5 (iCi/well) in a round 
bottom 96-well plate at 37°C in 5%  CO2 for 1 hr. Cell proliferation was determined 
as the mean ± SD of the uptake of [3H]TdR cpm for triplicate samples for each 
treatment.
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Figure  12 M o rp h o lo g ic a l  a lte ra t io n s  of U -937  ce lls  treated  witl 
retinoic acid U-937 cells were seeded at a density of 5 x 105 cells/ml in complete 
RPMI 1640 medium without (A) or with (B) 500 nM RA with medium changed 
every 24 hr for 6 days. U-937 cells were then harvested with low speed 
centrifugation. Morphological assessment of cells was made on Diff-quick stained 
(Lab Aids) Cytospin slide preparations with the use of a Cytospin 2 centrifuge. 
Photographs were taken under an inverted stage light microscope with magnification 
of 400. The appearance of indented, kidney shaped nucleus was indicated with 
arrows in photo B.
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Figure 13 The effects of RA on the proliferation of THP-1 celli
THP-1 cells were seeded at a density of 1.4 x 105 cells/ml in complete RPMI 1640 
medium without (control) or with 500 nM RA (sample 1 and 2). Every 24 hr, viable 
cell number was counted by using trypan blue exclusion and the medium was then 
fully replaced. 96 hr after initiation of the culture, RA was withdrawn from the 
medium of THP-1 cells in Sample 1. Data were plotted as mean ± SD of values 
from one representative experiment where three aliquots of cells in each treatment 
were counted at each time point.
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Figure 14 Tim e cou rse  of re t ino ic  ac id - in d u ced  d iffe ren tia tion  < 
U-937 and THP-1 cells m easured by NBT reduction Cells treated with 
(closed symbols) and without (open symbols) 500 nM RA were incubated with 0.2 
% NBT for 25 min at 37°C. The percentage of cells containing intracellular blue- 
black formazan deposits was then determined on wright-Giemsa stained cytospin 
slide preparations. Over 200 cells were assessed.
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3.2.3 The effect o f HCMV challenge on the proliferation of U-937 and 
THP-1 cells exposed to retinoic acid after the virus challenge
As described in previous studies, HCMV challenge of promonocytic U-937 and THP-1
cells resulted in an inhibition of cell proliferation. But the effects of HCMV challenge on the
proliferation of U-937 and THP-1 cells in the presence of RA remains unclear, which is the
focus of the investigation in the following experiments
U-937 and THP-1 cells were challenged with HCMV and UV-inactivated HCMV at m.o.i 
of 1 and 5, then were seeded at a cell density of 5 x 105 cells/ml in complete RPMI 1640 
medium containing 500 nM RA under the conditions as described in Section 2.2.4. Every 
24 hr, using Trypan Blue Exclusion, viable cell counts were performed on aliquots of cell 
suspensions before the medium was fully replaced.
As shown in Figure 15, at a m.o.i of 1 and in the presence of 500 nM RA, the virus 
challenged cells showed a growth pattern very similar to that of the cells treated with RPMI 
1640 medium and V.spun-out HFF SN. There seemed to be a difference in the viable cell 
counts between the virus-challenged and unchallenged U-937 cells 72 hr after initiation of 
the cultures when the virus was added at a m.o.i of 5. But this difference became 
insignificant when this body of data was assessed by one factor Anova Test. Some trypan 
blue positive cells were observed in virus-challenged cultures. Similar trends were 
observed in THP-1 cells under the same conditions as described above (Figure 16). 
[3H]TdR incorporation studies also showed no observable difference in the uptake of 
[3H]TdR between the cells of virus-challenged and unchallenged cultures in the presence of 
500 nM RA (Figure 17 and Figure 18). These results gave an impression that virus 
challenge may not result in, at least as analysed by the current technique, an observable 
disturbance of the cell proliferation when the cells are then exposed to RA after the virus 
challenge.
Figure 15 The effects of HCMV challenge on the proliferation of LI- 
937 cells exposed to RA after the virus challenge H C M V -ch a llen g ed  U- 
937 cells were cultured in RPMI 1640 medium containing RA for 6 days. Daily 
hem ocytom eter counts were done on aliquots of cell suspensions before the 
supernatants were harvested. Data were plotted as mean ± SD for three aliquots of 
each treatment of one experiment. There was no observable difference in the changes 
in viable cell counts between the virus-challenged and unchallenged cultures in the 
presence RA.
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Figure 16 The e ffects  of HCMV cha llenge on the pro liferation  o 
THP-1 cells  exposed to 500 nM RA after the virus challenge THP- 1  
cells were challenged with HCMV and UV-inactivated HCMV at a m.o.i. of 5 and 
then seeded at a density of 5 x 105 cells/ml in complete RPMI 1640 medium 
containing 500 nM RA. Every 24 hr, using trypan blue exclusion, viable cells were 
counted in aliquots of cell suspensions before the medium was replaced. Data were 
plotted as mean ± SD of values from one experiment where three aliquots of cells in 
each treatment were counted at each time point over 6 days.
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Figure 17 The effects of HCMV challenge on [3H]TdR uptake of U- 
937 exposed to RA after the virus challenge U-937 cells were challenged 
with HCMV and UV-inactivated HCMV at a m.o.i.of 5 and then seeded at a density 
of 5 x 105 cells/ml in RPMI1640 medium containing 500 nM RA. Every 24 hr after 
the medium was fully replaced, aliquots of cell suspensions were taken and 
incubated with [3H]TdR (0.5 (iCi/well) in a round bottom 96-well plate at 37°C in 
5% CO2 for 1 hr. Cell proliferation was determined as the mean ± SD of the 
incorporation of [3H]TdR for triplicates of each treatment. This experiment was 
repeated at a m.o.i. of 1 and a similar pattern were obtained.
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Figure 18 The effects of HCMV challenge on [3 H]TdR u p take  ol 
THP-1 exposed to RA after the virus challenge THP-1 cells were 
challenged with HCMV and UV-inactivated HCMV at a m.o.i.of 5 and then seeded 
at a density of 5 x 105 cells/ml in RPMI 1640 medium containing 500 nM RA. 
Every 24 hr after the medium was fully replaced, aliquots of cell suspensions were 
taken and incubated with [3H]TdR (0.5 jiCi/well) in a round bottom 96-well plate at 
37°C in 5% C O 2 for 1 hr. Cell proliferation was determined as the mean ± SD of 
the incorporation of [3H]TdR for triplicates of each treatment. This experiment was 
repeated at a m.o.i. of 1 and similar trends were obtained.
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3.2.4 The effects of HCMV challenge on the growth of U-937 and THP-1 
cells continually maintained in the media containing retinoic acid
U-937 and THP-1 cells were initially cultured in complete RPMI 1640 medium containing
500 nM RA for 6 days with medium being fully replaced every 24 hr. These RA-treated
cells were then challenged with HCMV and UV-inactivated HCMV at an m.o.i. of either 1
or 5 in the absence of RA and then seeded at a cell density of 5 x 105 cells/ml in RPMI 1640
medium containing RA. At 24 hr intervals, the cultures were sampled and the viable cell
counts obtained as in section 2.2.4.
As shown in Figure 19, virus-challenged U-937 cells showed a slight decrease in viable cell 
counts at 24 hr post-challenge when compared with unchallenged cultures. A similar trend 
in cell numbers was observed in both virus-challenged and unchallenged cells from 24 hr to 
144 hr. Although observable difference in the viable cell counts was observed at 96 hr 
post-challenge between the cells of virus-challenged and unchallenged cultures, the 
difference was insignificant when assessed by one factor Anova Test. Regardless of the 
m.o.i. of HCMV used the virus-challenged cultures showed a similar growth pattern. 
Similar results were also obtained from THP-1 cells infected and sampled in the same way 
(Figure 20).
When the effect of HCMV challenge on [3H]TdR uptake of U-937 cells continually exposed 
to RA was determined, both virus-challenged and unchallenged cultures showed a markedly 
decreased level of [3H]TdR uptake at 24 hr post-challenge, then followed by a gradual 
recovery in [3H]TdR uptake over the rest of time period of the culture (Figure 21). Cells 
treated with RPMI 1640 medium and V spun-out HFF SN showed a significantly higher (p 
= 0.05) [3H]TdR uptake when compared with that of virus-challenged cells at 144 hr post­
challenge. Measurements of [3H]TdR uptake by THP-1 cells showed no observable 
difference between THP-1 cells of virus-challenged and unchallenged cultures over the 
same time periods (Figure 22).
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As it has recently been reported that human peripheral blood monocytes and macrophages 
become permissive for HCMV infection under certain conditions, it is necessary to ascertain 
whether U-937 cells become permissive for HCMV infection under the present conditions. 
The supernatants harvested from the virus-challenged U-937 cells at 120 and 140 hr post­
challenge were tested in a TCID50 assay. No CPE was visualised by Quick-Dip stain when 
this TCID50 assay was read after seven days, indicating that, at 120 and 140 hr post­
challenge, no detectable extracellular HCMV was yielded by the U-937 cells under the 
stated conditions.
Figure 19 The effects of HCMV challenge on the proliferation of 
U-937 cells exposed to RA before and after the virus challenge U-
937 cells were challenged with HCMV (at m.o.i. of 1 or 5) after being treated with 
500 nM RA for 6 days. Virus challenged cells were then maintained in RPMI 1640 
medium containing RA for another 6 days. Daily haemocytometer counts were done 
on triplicate aliquots of cell suspensions before the supernatants were harvested. 
There was no difference in the viable cell counts between the virus-challenged and 
unchallenged cultres in the presence of RA.
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Figure 20 The effects of HCMV challenge on the proliferation of 
THP-1 cells exposed to RA before and after the virus challenge
THP-1 cells were challenged with HCMV after being treated with RA for 6 days. 
Virus-challenged cells were then maintained in R P M I1640 medium containing RA 
for another 6 days. Daily haemocytometer counts were done on triplicat aliquots of 
cell suspensions before the medium was replaced. There was no observable 
difference in the viable cell counts between the virus-challenged and unchallenged 
cultures tin the presence of RA.
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Figure 21 The effects of HCMV challenge on [3 H ]TdR  uptake  
of U -937 cells  con tinuous ly  exposed to RA U-937 cells were 
challenged with HCMV and UV-inactivated HCMV in the absence of RA at a 
m.o.i. of 5 after being treated with 500 nM RA for 6 days. Challenged cells 
were seeded in complete RPMI1640 medium containing 500 nM RA. Every 
24 hr after the medium was fully replaced, aliquots of cell suspensions were 
taken and incubated with [3H]TdR (0.5 jiCi/well) in a round bottom 96-well 
plate at 37°C in 5% C02 for 1 hr. Cell proliferation was determined as the 
mean ± SD of the uptake of [3H]TdR for triplicates of each treatment.
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Figure 22 The effects of HCMV challenge on [3H]TdR uptake ol 
THP-1 cells continuously exposed to RA THP-1 cells were challenged with 
HCMV and UV-inactivated HCMV in the absence of RA at a m.o.i. of 5 after being 
treated with 500 nM RA for 6 days. Then challenged cells were seeded in complete 
RPMI 1640 medium containing 500 nM RA. Every 24 hr after the medium was 
fully replaced, aliquots of cell suspensions were taken and incubated with [3H]TdR 
(0.5 |LLCi/well) in a round bottom 96-well plate at 37°C in 5%  CO2  for 1 hr. Cell 
proliferation was determined as the mean ± SD of the uptake of [3H]TdR for 
triplicates of each treatment. This experiment was repeated once at a m.o.i. of 1 and 
similar trends were obtained.
Control
V. spun-out HFF SN 
AD 169 
UV-AD169
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3.2.5 The effects o f HCMV challenge on the proliferation of U-937 cells 
treated with RA prior to the challenge
U-937 cells were cultured in complete RPMI 1640 medium containing 500 nM RA for 6 
days with medium fully replaced every 24 hr. These RA-treated cells were challenged with 
HCMV and UV-inactivated HCMV at an m.o.i. of 5 in the absence of RA, then the cells 
were seeded at a cell density of 5 x 105 cells/ml in RPMI 1640 medium without RA
Viable cells were determined by using the method of Trypan Blue Exclusion. Data from 
one representative experiment is presented in Figure 23. Virus challenged cells proliferated 
more slowly than that of unchallenged cells. The difference was most marked over the last 
72 hr of the 6 day culture period and significant differences was apparent at 120 and 144 hr. 
Figure 24 shows that the [3H]TdR incorporation of virus-challenged cells was lower than 
that of unchallenged cells. The difference at 144 hr was significant (p = 0.05).
The supernatants harvested from the HCMV challenged U-937 culture at 120 and 140 hr 
were tested in a TCID50 assay. No CPE was visualised by Diff-Quick stain (Lab Aids) 
under a light microscope when the cells observed seven days after setting up the TCID50 
assay, indicating that no extracellular HCMV was present in U-937 culture fluid at 120 and 
140 hr post-challenge.
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F ig u re  23 T he effec ts  o f  H CM V cha llen ge  on the p ro lifera tio n  o f U-937  
exposed to RA prior to the challenge U-937 cells were challenged with HCMV 
and UV-inactivated HCMV at a m.o.i. of 5 after being treated with 500 nM RA for 6 
days (0 time), then maintained in RPMI 1640 medium without RA. Using trypan 
blue exclusion, viable cell counts were performed at daily intervals on aliquots of cell 
suspensions before the medium was fully replaced. Data were plotted as mean ± SD 
of values from one experiment where three aliquots of cells in each treatment were 
counted at each time point over 6 days.
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F ig u re  24 The effects o f H CM V challenge on [3 H ]T dR  uptake o f U- 
937 exposed to RA prior to the challenge U-937 cells were challenged 
with HCMV and UV-inactivated HCMV at a m.o.i. of 5 after being treated 
with 500 nM RA for 6 days (0 time). Challenged cells were then 
maintained in RPMI 1640 medium without RA. Every 24 hr, aliquots of 
cell suspensions were taken and incubated with [3H]TdR (0.5 jiCi/well) in 
a round bottom 96-well plate at 37°C in 5% CO2 for 1 hr. Cell 
proliferation was determined as the mean ± SD of the uptake of [3H]TdR 
for triplicates of each treatment. Presented data are pooled results from two 
experiments.
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3.3 THE INHIBITOR PRODUCTION BY PROMONOCYTIC U-937 AND 
THP-1 CELLS
Recently it has been reported that HCMV challenge of human peripheral blood monocytes 
enhanced the production of an antagonist of IL-1, which suppresses thymocyte 
proliferation. The effects of HCMV challenge of U-937 and THP-1 cells on the production 
of the growth factor(s) which may affect thymocyte proliferation was ascertained.
A standard thymocyte assay was modified to assess the growth factor production of 
promonocytic U-937 and THP-1 cells as described in Section 2.3.0. Briefly, thymocytes 
obtained from 6 - 8  week old BALB/c mice were seeded at a density of 1 x 106 cells/ml in 
R P M I1640 medium supplemented with PHA and rIL-2 at 37°C in 5% CO2. Controls were 
the thymocytes cultured under the same conditions, But lacking the addition of supernatants 
from U-937 or THP-1 cells. Thymocyte proliferation was assessed by measuring [3H]TdR 
incorporation over the last 24 hr of the 72 hr culture. Supernatant activity was determined 
as the mean ±  SD of the uptake of [3H]TdR in cpm for triplicates. Supernatants of U-937 
and THP-1 cells were collected when the culture media were fully replaced every 24 hr. 
Supernatants harvested at 24 hr, 72 hr, 96 hr and 144 hr were added to the thymocyte 
cultures at a final concentration of 10 % v/v or 20 % v/v.
As shown in Table 4, supernatants from U-937 and THP-1 cultures had a strong 
suppressive effect on thymocyte proliferation. This suppression was increased with the 
length of time during which the harvested supernatants had been in contact with the U-937 
or THP-1 cells. The extent of the inhibition was not affected by increasing the supernatant 
from 10 % v/v to 20 % v/v. Data presented in Table 4 was from one representative 
thymocyte assay to which 10% v/v supernatants were added.
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Table 4 Inhibitor production by p ro m o n o c y tic  U -9 3 7  a n d  T H P -1  cells
Thymocytes obtained from a 6 - 8 week old BALB/c mouse were incubated in a 
round bottom 96-well plate in complete RPMI 1640 medium supplemented with 
PH A (ljag/ml) and rIL-2 (2U/ml). Supernatants were harvested from U-937 and 
THP-1 cultures every 24 hr, but only those collected at 24 hr, 72 hr, 96 hr and 144 
hr were added to the thymocyte culture at a final concentration of 10 % v/v. 
Controls were the thymocytes cultured under the same conditions, but lacking 
supernatants from U-937 and THP-1 cells. Thymocyte proliferation was assessed 
by measuring the incorporation of [3H]TdR (0.5 pCi/well) over the last 24 hr at 
37°C in 5% CO2. The supernatant activity was determined as the mean ± SD of the 
uptake of [3H]TdR in cpm for triplicates.
Exp. Addition of supernatant 
from promonocytes
[3H]TdR uptake of 
thymocytes (cpm)
U-937 / 2444713891
24 hr supernatant 66601752
72 hr supernatant 36811449
96 hr supernatant 37491632
144 hr supernatant 22901392
THP-1 / 1866512379
24 hr supernatant 29241298
72 hr supernatant 29461358
96 hr supernatant 22911517
144 hr supernatant 16691102
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3.4  TH E EFFEC TS OF R ETINO IC ACID ON THE FACTO R  
PRODUCTION BY U-937 AND THP-1 CELLS
The effects of the differentiation inducer RA on factor production by U-937 and THP-1 cells 
was studied. Both cell lines were treated with 500 nM RA for 6 days during which their 
growth media were fully harvested every 24 hr. The supernatants harvested at 24 hr, 72 hr, 
96 hr and 144 hr were tested for their effects on thymocyte proliferation. The control was 
thymocytes cultured in complete RPMI 1640 medium with or without 500 nM RA, but 
having no supernatants from U-937 or THP-1 cell cultures.
As shown in Table 5, the addition of RA alone to the thymocyte culture did not affect the 
thymocyte proliferation, thus it would be possible to suggest that any significant fluctuation 
in [3H]TdR uptake of test thymocyte cultures could be regarded as the effects resulting from 
the addition to the thymocyte cultures of the supernatants harvested from U-937 and THP-1 
cells.
Supernatants from both U-937 and THP-1 cells significantly suppressed thymocyte 
proliferation (Table 5). When U-937 cultures were exposed to retinoic acid, the suppressive 
effect was less marked at 96 hr or after, suggesting that the differentiated cells were less 
suppressive. The treatment of THP-1 cells by retinoic acid also reduced the suppressive 
effect but there was no influence of time
Taken together, These results may suggest that cells which are undergoing differentiation 
under the inducement of RA could be less effective in suppression of thymocyte 
proliferation. But these results did not discriminate whether the reduced suppression effect 
of the supernatant on thymocyte proliferation was due to a reduced inhibitor production or to 
an increased production of antagonists to the inhibitor(s).
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Table 5  T h e  effec ts  o f  R A  tre a tm e n t  on  in h ib ito r  p ro d u c tio n  by U -937 a n d  
T H P - l  ce lls  Thymocytes obtained from a 6 - 8 week BALB/c mouse were 
incubated in a round bottom 96-well plate in complete RPMI 1640 medium 
supplemented with PHA (ljig/m l) and rIL-2 (2U/ml). Supernatants were 
harvested every 24 hr from U-937 and THP-l cultures treated with 500 nM RA, 
but only those collected at 24 hr, 72 hr, 96 hr and 144 hr were added to the 
thymocyte culture at a final concentration of 20% v/v. Controls were the 
thymocytes cultured under the same conditions, except the culture contained 500 
nM RA and lacking growth medium from U-937 or THP-l cultures. Thymocyte 
proliferation was assessed by measuring the incorporation of [3H]TdR (0.5 
jaCi/well) over the last 24 hr at 37°C in 5% CO2. Supernatant activity was 
determined as the mean ± SD of the uptake of [3H]TdR in cpm for triplicates of one 
experiment.
Exp. Addition of supernatant 
from promonocytes
[3H]TdR uptake of 
thymocytes (cpm)
U-937 / 26659±1617
500 nM retinoic acid 259911792
24 hr supernatant 19761203
72 hr supernatant 2242156
96 hr supernatant 1224411549
144 hr supernatant 116611316
TH P-l / 19328±2379
500 nM retinoic acid 2048613891
24 hr supernatant 81781500
72 hr supernatant 915511327
96 hr supernatant 56531730
144 hr supernatant 935412218
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3.5  TH E EFFECTS OF HCM V CH ALLENG E ON THE FACTOR  
PRODUCTION OF U-937 AND THP-1 CELLS
U-937 cells were challenged with infectious HCMV and UV-inactivated HCMV under the 
conditions as described in Section 2.2.4. Supernatants were harvested when the culture 
media were fully replaced every 24 hr. The supernatants collected at 24 hr, 72 hr, 96 hr and 
144 hr after initiation of the virus challenge were added to thymocyte cultures as previously 
described in section 3.3. Control thymocytes were cultured under the same conditions, but 
containing no supernatants of U-937 cells or containing supernatants collected either from 
U-937 cells maintained in RPMI 1640 medium or from U-937 cells initially treated with V 
spun-out HFF SN. Previous studies had indicated that challenge of HCMV and UV- 
inactivated HCMV could inhibit the proliferation of both cell lines. The cell number in virus 
challenged cultures would then be less than that in unchallenged cultures, which would be 
an important factor in the consideration of the extent of the suppression effect on thymocyte 
proliferation. Thus the thymocyte proliferation was expressed in cpm of [3H]TdR uptake of 
thymocytes per U-937 cell and was plotted against the time points where those supernatants 
were collected.
Thymocytes cultured in the growth medium containing no supernatants from U-937 cells 
showed the highest [3H]TdR incorporation in terms of the mean ± SD of the uptake of 
[3H]TdR in cpm for triplicates.
When the 24 hr supernatants collected from U-937 cells treated with HCMV, UV- 
inactivated HCMV and V spun-out HFF SN were tested for the thymocyte proliferation 
suppressive activity, the supernatant collected from the cells challenged with HCMV 
contained the highest (P = 0.01) suppression activity. No significant difference (p = 0.05) 
was seen in the suppressive activity of the supernatants of U-937 cells treated with UV- 
inactivated HCMV and V spun-out HFF SN. A gradual increase in the inhibition on
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thymocyte proliferation was observed with the addition to the thymocyte cultures of the 
supernatants collected at the later time intervals. The strongest suppression was produced 
by the supernatant of U-937 cells treated with RPMI 1640 medium alone (p = 0.01). It is 
tempting to speculate that the fibroblast supernatant contained a factor which interfered with 
the production of the factor by the U-937 cells. Virus challenge tended to counteract the 
effect of the fibroblast factor.
As shown in Figure 26, exposure of thymocytes to the growth media containing virus- 
challenged THP-1 cells' supernatants collected at 24 hr post-challenge showed a higher 
thymocyte proliferation (p = 0.01). But this effect was gradually reduced in the THP-1 cell 
supernatants collected at 24 hr afterwards. Supernatants harvested from THP-1 cells treated 
with RPMI medium and V spun-out HFF SN contained stronger suppression activity on 
thymocyte proliferation, particularly in the first 24 - 48 hr after virus challenge. These data 
suggested that THP-1 cells challenged with HCMV and UV-inactivated HCMV could 
become less effective in the suppression of thymocyte proliferation.
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F ig u re  25 The effects of HCMV challenge on the inhibitor production by U- 
937 cells Thymocytes derived from 6 - 8 week old BALB/c mice were seeded at a 
density of 1 x 106 cells/ml in RPMI 1640 medium containing PH A (ljig/ml) and 
rIL-2 (2U/ml) at 37°C in 5% CO2 . Supernatants of U-937 cells were collected when 
the culture media were fully replaced every 24 hr. The supernatants collected at 24 
hr, 72 hr, 96 hr and 144 hr were added to thymocyte cultures at a final concentration 
of 20 % v/v. Thymocyte proliferation was assessed by measuring the incorporation 
of [3H]TdR (0.5 jaCi/well) over the last 24 hr of the 72 hr culture. Supernatant 
activity was determined as the mean ± SD of the value of [3H]TdR uptake in 
cpm/cell of U-937 for triplicates of one experiment. One factor Anova test was 
used in data analysis.
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F igu re  26 The effects o f H CM V challenge on in h ib itor  p roduction  by TH P-1  
cells Thymocytes derived from 6 - 8  week old BALB/c mice were seeded at a 
density of 1 x 106 cells/ml in RPMI 1640 medium containing PHA (lpg/ml) and 
rIL-2 (2U/ml) at 37°C in 5% CO2 . Supernatants of THP-1 cells were collected 
when the culture media were fully replaced every 24 hr. The supernatants collected 
at 24 hr, 72 hr, 96 hr and 144 hr were added to thymocyte cultures at a final 
concentration of 20 % v/v. Thymocyte proliferation was assessed by measuring 
the incorporation of [3H]TdR (0.5 jaCi/well) over the last 24 hr of the 72 hr 
culture. Supernatant activity was determined as the mean ± SD of the value of 
[3H]TdR uptake in cpm/cell of U-937 for triplicates of one representative 
experiments. One factor Anova test was used in data analysis.
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3.6  THE EFFEC TS OF HCM V CHALLENGE ON THE FACTOR  
PRODUCTION OF U-937 AND THP-1 CELLS EXPOSED TO RETINOIC  
ACID AFTER THE VIRUS CHALLENGE
U-937 cells were challenged with HCMV and UV-inactivated HCMV as described in 
Section 2.2.4. These virus-challenged cells then were seeded at a density of 5 x 105 
cells/ml in RPMI 1640 medium containing 500 nM RA and supernatants collected at daily 
intervals when the medium was fully changed. The thymocyte assay was performed under 
the conditions as described in section 3.3 using the supernatants at 20 % v/v. All controls 
were set up as described previously in Section 3.5 except retinoic acid was added to the 
growth medium to the final concentration of 500 nM. Thymocyte proliferation was 
expressed in cpm of [3H]TdR uptake in thymocytes per cell of U-937 and plotted against the 
time points where those supernatants were collected.
As shown in Figure 27, the supernatants harvested from U-937 cells treated with RPMI 
1640 medium and V spun-out HFF SN at 24 hr after initiation of the treatment exerted 
significantly higher suppression on thymocyte proliferation (p = 0.05). However the 
suppression activity was reduced in the supernatants collected at the time points of 72 hr and 
96 hr, and significantly at 144 hr (p = 0.05).
Supernatants collected from U-937 cells challenged with HCMV and UV-inactivated HCMV 
at 24 hr post-challenge was less effective in the suppression of thymocyte proliferation. The 
suppression effect was increased in the supernatants collected at 72 hr post-challenge, which 
was then followed by a reduction in the suppression of the supernatants collected at 96 hr 
afterwards.
Taken together, these results may indicate that the vims challenged U-937 cells, which were 
then undergoing differentiation in the presence of RA, were a less effective producer of 
suppression activity for thymocyte proliferation particularly in the very early stage after
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initiation of the virus challenge. However, with time these virus challenged cells produced 
more suppress for thymocyte proliferation than the controls.
As shown in Figure 28, thymocytes cultured in the growth medium containing the 
supernatants collected from THP-1 cells, regardless of the initial treatment of THP-1 cells, 
showed a similar level of [3H]TdR incorporation. It seemed to be that challenge of THP-1 
cells with HCMV appear to not influence their growth factor production.
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F igure  2 7  The effects o f  H CM V challenge on the inh ib itor production  by U- 
937 cells exposed to RA after the virus challenge Supernatants were harvested 
every 24 hr from the virus challenged U-937 cells which were exposed to RA after 
the challenge. Supernatants collected at 24 hr, 72 hr, 96 hr and 144 hr were added 
to thymocytes derived from 6 - 8 week old BALB/c mice at a final concentration of 
20 % v/v. Thymocytes were seeded at a density of 1 x 106 cells/ml in RPM I1640 
medium supplemented with PHA and rIL-2 at 37°C in 5%  C 02. Thymocyte 
proliferation was assessed by measuring the incorporation of [3H]TdR (0.5 
|iCi/well) over the last 24 hr of the 72 hr culture. Supernatant activity was 
determined as the mean ± SD of the [3H]TdR uptake in cpm/cell of U-937 for 
triplicates of one representative experiment. One factor Anova test was used in data 
analysis.
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F igure  28 The effects o f H CM V challenge on the in h ib ito r  p rod u ction  by 
T H P-1 ce lls  exposed to RA after the virus ch a llen ge  Supernatants were 
harvested every 24 hr from the virus challenged THP-1 cells which were exposed to 
RA after the challenge. Supernatants collected at 24 hr, 72 hr, 96 hr and 144 hr 
were added to thymocytes derived from 6 - 8 week old BALB/c mice at a final 
concentration of 20 % v/v. Thymocytes were seeded at a density of 1 x 106 
cells/ml in RPMI 1640 medium supplemented with PHA and rIL-2 at 37°C in 5% 
C 0 2. Thymocyte proliferation was assessed by measuring the incorporation of 
[3H]TdR (0.5 ftCi/well) over the last 24 hr of the 72 hr culture. Supernatant activity 
was determined as the mean ± SD of the [3H]TdR uptake in cpm/cell of THP-1 for 
triplicates of one representative experiment. One factor Anova test was used in data 
analysis.
Time (hr)
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3.7 THE EFFECTS OF HCMV CHALLENGE ON THE FACTOR  
PRODUCTION OF U-937 AND THP-1 CELLS CONTINUALLY EXPOSED 
TO RETINOIC ACID
U-937 and THP-1 cells were cultured in the presence of retinoic acid for 6 days prior to the 
virus challenge which was performed under the conditions as described in section 2.2.4. 
Virus-challenged cells were then seeded at a density of 5 x 105 cells/ml in RPMI 1640 
medium containing 500 nM RA. Supernatants were then harvested when the culture media 
were fully replaced every 24 hr. The supernatants collected at 24 hr, 72 hr, 96 hr and 144 
hr were added to thymocyte cultures at a final concentration of 20 % v/v as previously 
described in Section 2.3. Controls were the thymocytes cultured in the growth medium 
containing 500 nM retinoic acid or the supernatants of U-937 cells treated with either RPMI 
1640 medium alone or V spun-out HFF SN. Thymocyte proliferation was assessed by 
measuring the incorporation of [3H]TdR over the last 24 hr of the 72 hr culture. Thymocyte 
proliferation was expressed in cpm of [3H]TdR uptake in thymocytes per cell of U-937 and 
plotted against the time points where those supernatants were collected.
As shown in Figure 29, thymocyte proliferation was less suppressed with addition of the 
supernatants collected at 24 hr post-challenge from U-937 cells which were treated with 
HCMV and UV-inactivated HCMV (p = 0.01). The suppression strengthened in the 
supernatants collected from the virus challenged U-937 cells after 24 hr. Supernatants 
collected at daily intervals from unchallenged U-937 cells exhibited a gradual decrease in 
suppression effect in the thymocyte assay. These results indicate that virus challenge of 
RA-treated U-937 cells maintained in RA enhances their suppressive effect on thymocyte 
proliferation.
A similar study was also carried out with THP-1 cells under the conditions described above 
(Figure 30). Virus challenge appeared not to disturb the growth factor production by the 
THP-1 cells, as no significant difference was showed in [3H]TdR uptake of thymocytes
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exposed to supernatants derived from control and virus challenged THP-1 cells maintained 
in RA.
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Figure 29 The effects of HCM V challenge on the in h ib itor  production  by U- 
937 cells continuously exposed to RA After the virus challenge, the supernatants 
were collected from U-937 cells when the culture medium was fully replaced every 
24 hr. The U-937 cells were continuously exposed to 500 nM RA. The 
supernatants collected at 24 hr, 72 hr , 96 hr and 144 hr after the virus challenge 
were added to thymocyte cultures at a final concentration of 20 % v/v. Thymocytes 
were obtained from 6 -8  week old BALB/c mice and seeded at a density of 1 x 106 
cells/ml in RPMI 1640 medium supplemented with PHA and rIL-2 at 37 °C and 5 % 
CO2 . Thymocyte proliferation was assessed by measuring the uptake of [3H]TdR 
(0.5 |iCiAvell) over the last 24 hr of the 72 hr culture. The supernatant activity was 
determined as the mean ± SD of the [3H]TdR uptake in cpm per cell of U-937 for 
triplicates of one representative experiment. One factor Anova test was used in data 
analysis.
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F igure  30 The effects o f H CM V challenge on the in h ib itor  p rod u ction  by 
T H P -i c e lls  co n tin u o u sly  exp osed  to RA After the virus challenge, the 
supernatants were collected from THP-1 cells when the culture medium was fully 
replaced every 24 hr. The THP-1 cells were continuously exposed to 500 nM RA. 
The supernatants collected at 24 hr, 72 h r, 96 hr and 144 hr after the virus challenge 
were added to thymocyte cultures at a final concentration of 20 % v/v. Thymocytes 
were obtained from 6 -8  week old BALB/c mice and seeded at a density of 1 x 106 
cells/ml in RPMI 1640 medium supplemented with PHA and rIL-2 at 37 °C and 5 % 
CO2 . Thymocyte proliferation was assessed by measuring the uptake of [3H]TdR 
(0.5 jiCi/well) over the last 24 hr of the 72 hr culture. The supernatant activity was 
determined as the mean ± SD of the [3H]TdR uptake in cpm per cell of THP-1 for 
triplicates of one representative experiment. One factor Anova test was used in data 
analysis.
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4.1 DISCUSSION
4.1.1 Limitations of the experimental system
It is very important to recognise the limitations of the experimental system employed in the 
present study before speculating upon the general significance of the results.
It was an in vitro study. Although it is possible to get HCMV infected peripheral blood 
monocytes from the victims of HCMV infection, this manipulation is not usually done for 
the purposes of basic medical research. This is because of not only ethical reasons, but also 
technical difficulties with studying the virus in people. In fact, in vitro studies could provide 
invaluable information for the understanding of what could happen in vivo.
At the present time, it is very difficult to obtain populations of monocytes of high purity, 
and other cell types which have secondary effects on monocytes which may obscure the 
direct the effects of HCMV. Furthermore, monocytes from peripheral blood are not a 
homogeneous population (Reinsman et al., 1990). U-937 and THP-1 cell lines were 
selected as an in vitro model in this study. Both cell lines are derived from leukemia 
patients, and belong to the category of monocytes, within the subpopulation of pro­
monocytes. They are highly homogenous and easy to work with. However, not every 
variable parameter present in vivo in human peripheral blood monocytes could be replicated 
exactly in vitro, in U-937 and THP-1 cells. Also, any phenomenon observed in these two 
cell lines does not necessarily indicate the same phenomenon will be seen from peripheral 
blood monocytes.
HCMV AD 169 is an attenuated, laboratory adapted strain, thus it could interact with U-937 
and THP-1 cells in a way which could be quite different from the interactions between a 
clinical HCMV isolates and host cells.
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RA was used as an inducer of cell differentiation. The reason for choosing this reagent in 
this study is because it is less potent than other differentiation inducers, such as TPA. RA 
takes quite a long time (about 5 - 6  days) to reach a marked inhibition of cell proliferation 
and induction of cell differentiation, thus giving a long enough time period for the 
observation of the effects of HCMV challenge on the cell proliferation and differentiation.
4.1.2 The effects of retinoic acid on the proliferation of U-937 and THP-1
RA is an active metabolite of vitamin A which is essential in normal cell growth and 
development (Bedo et al., 1989). It inhibits proliferation of myeloid leukemia cells, such as 
U-937 and THP-1 cells and induces these cells to differentiate to reach a monocyte-like cell 
stage . At the present time, the mechanism of the action of RA is a matter of speculation as 
described in section 1.2.2.
In the absence of RA, U-937 cells proliferated faster than did THP-1 cells (Figure 3). 
Along the path of myelopoiesis, the more mature the cell is, the less capable of further 
division it is (Hemmi et al., 1985), thus it seems that the THP-1 cell line is probably at a 
more mature stage than the U-937 cell line.
In the presence of RA, it was shown that the proliferation of both cell lines was markedly 
inhibited measured by the counts of viable cell number (Figure 10 and Figure 13) and the 
level of [3H]TdR incorporation (Figure 11 and Figure 14). However, in both cell lines a 
low level of cell proliferation continued in the presence of RA, indicating the proliferation of 
a small proportion of less RA sensitive variant cells as has been reported for THP-1 cell 
lines (Nakamura et al., 1986). This population of less RA sensitive cells were likely 
responsible for the increased cell proliferation after RA was withdrawn from cultures. 
However, low RA sensitivity of the proportion of these cells is changeable. Nakamura et 
al. (1986) reported that in the presence of some other cytokines, e.g. IFN, these less RA
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sensitive cells could become sensitive to RA even at extremely low RA concentrations, e.g. 
10 nM.
Observable morphological alterations were concomitant with the RA-associated suppression 
of cell proliferation in U-937 cells, but not in THP-1 cells in the present study. But the 
latter does not mean THP-1 cells didn't enter their differentiation. After treated with 500 nM 
RA for 6 days, 45% THP-1 and 85% U-937 cells were capable of reducing NBT which is 
characteristic for differentiated monocytes. Hemmi et a l  (1985) reported that after treating 
THP-1 cells with 1 jiM RA for 5 days, about 10 - 30% of the THP-1 cells attached to the 
flask surface and that functional maturation concomitant with the RA-induced inhibition of 
cell proliferation was observed. However in Hemmi's study no morphological differences 
were observed between RA-treated and nontreated THP-1 cells on Wright-Gimesa stained 
cytospin slide preparations. This suggests that morphological alterations may not be 
necessarily concomitant with functional maturation in some cell lines, such as THP-1 cells. 
It is well known that functional alterations normally occur before the appearance of 
observable morphological alterations in both physiological and pathological situations.
The results of the present study suggest that differentiation was induced in U-937 and, to a 
certain extent, in THP-1 cells after initiation of the treatment with 500 nM RA over a period 
of 6 days. A markedly suppressed cell proliferation is concomitant with the differentiation 
process induced by RA.
4.1.3 The effects of RA on inhibitor production by U-937 and THP-1
Both U-937 and THP-1 cells could produce factors which suppress the proliferation of 
mouse thymocytes/human T lymphocytes (Wilkins et a l, 1983; Fujiwra and Ellner, 1986; 
Tsai et al. , 1986; Fujiwra et a l , 1987; Gaffney et a l , 1989; Sugimura et a l , 1989). 
Among those reports, only Fujiwra et a l  (1987) clearly reported that a factor spontaneously 
produced by promonocytic U-937 cells suppressed an IL-1, IL-2, and PHA induced
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blastogenesis in mouse thymocytes. This factor was non-competitive for IL-1 or PHA, not 
dialyzable and with a molecular weight of about 85 Kd. Present data showed that 
supernatants harvested from promonocytic U-937 and THP-1 cell cultures at a various time 
contained a marked suppression effect on the mouse thymocyte proliferation (Table 4). This 
suppression increased with the length of time during which the harvested supernatants had 
been in contact with the U-937 and THP-1 cells. As far as the nature of the inhibitor is 
concerned, present results only point out that this factor suppressed the mouse thymocyte 
proliferation primed by PHA and rIL-2.
The new finding of the present study is that treatment of U-937 and THP-1 cells with RA 
could partially relieve their suppression on thymocyte proliferation (Table 5). When 
undergoing differentiation under the inducement of RA, THP-1 and U-937 cells may 
become less effective in the suppression of thymocyte proliferation. But present results did 
not discriminate whether the decreased suppression of thymocyte proliferation was due to a 
reduced inhibitor production or an increased production of antagonist(s) to the inhibitor by 
U-937 and THP-1 cells. Furthermore, as the mechanism of the effect of RA on cell 
proliferation and differentiation remains unclear at the present time, it would be arbitrary to 
speculate upon the link between the cell differentiation and the inhibitor production in 
general terms.
4.1.4 The effects of HCMV challenge on the inhibitor of production of U- 
937 and THP-1
The major function of monocytes and macrophages is to present antigens and deliver 
biologically active molecules (e.g. IL-1) to immune effector cells to mediate the immune 
response. Available information has suggested that infection of human peripheral blood 
monocytes with HCMV resulted in a metabolic derangement in monocytes and impaired 
their ability both to produce and to respond to physiological mediators of the immune 
response (Kapasi and Rice, 1988). An unbalanced production of stimulators and their 
corresponding inhibitors by HCMV infected monocytes have been reported (Rodgers et al.,
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1985; Amento et a l , 1985; Turtinen et a l , 1989; Hannum et a l , 1990; Moses and Garnett, 
1990).
In the present study, promonocytic THP-1 cells challenged with HCMV and UV-inactivated 
HCMV produced factor(s) which resulted in a reduced inhibition of thymocyte proliferation 
primed by PHA and rIL-2 (Figure 23). The mechanism of the decreased inhibition of 
thymocyte proliferation is not clear. It could result from either a decreased inhibitor 
production or an increased production of a stimulator by the virus-challenged THP-1 cells. 
Presented information which were mainly focused on IL-1 production has suggested that 
THP-1 cells could produce both IL-1 and IL-1 inhibitors. A detectable level of IL-1 was 
produced by HCMV challenged promonocytic THP-1 cells at 24 hr p.i. (Turtinen et al., 
1989). Unfortunately, Turtinen didn't make mention of IL-1 inhibitor production in his 
study.
HCMV challenge appeared to not disturb the inhibitor production by the THP-1 cells in the 
presence of RA (Figure 28 and 30). The reason is not known at the moment. It may result 
from the RA treatment which could induce an antiviral state in the infected cells, thus 
eliminating the effects of HCMV challenge. Nakashima et a l  (1987) reported that RA 
treatment significantly inhibited the replication of human immunodeficiency virus in human 
T lymphocyte virus-1-positive MT-4 cells. Ho et al. (1989) demonstrated that a higher 
antiviral activity was consistently obtained when a large dose of RA (0.1 - 10 pM) was 
added to cultures of WISH cells in the presence of IFN-a or -b. On the other hand, it may 
also result from the intracellular status of THP-1 cells, which will be discussed in Section 
4.1.5.
Challenge of promonocytic U-937 cell with infectious HCMV enhanced the suppressive 
effects of its medium on thymocyte proliferation, but not with the challenge of UV- 
inactivated HCMV (Figure 25). The suppression effect seems to be dependent upon the
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infectivity of the virus. The reason why there was such a different response to the challenge 
of infectious and UV-inactivated HCMV in promonocytic U-937 cells is not clear. 
Although there are pieces of information concerning the inhibitor production of 
piomonocytic U-937 cells, this body of information is mainly focused on the subject of the 
production of IL-1 inhibitors. Rodges et a l  (1985) reported that no loss of IL-1 activity 
was observed when U-937 cells were infected with HCMV which had been heat or UV- 
inactivated, and the production of one inhibitor of thymocyte proliferation was only 
observed in promonocytic U-937 cells infected with infectious HCMV.
Challenge of differentiated U-937 cells with the virus eventually enhanced their efficiency in 
the suppression of thymocyte proliferation although there was an initial relief in the 
suppression (figure-29). The same effect was observed when the virus-challenged 
promonocytic U-937 cells were undergoing differentiation under the inducement of RA 
(Figure 27). There is no information available with the respect to the inhibitor production 
by the differentiating or differentiated U-937 cells. Available information centred on the 
production of IL-1 and IL-1 inhibitors by peripheral blood monocytes demonstrated that 
HCMV challenge of monocytes could unbalance the production of IL-1 and its inhibitors, 
resulting in a dominant production of IL-1 inhibitor(s) (Rodgers et al., 1985; Arend et al., 
1989; Moses and Garnett, 1990).
In either differentiating U-937 cells or differentiated U-937 cells, UV-inactivated and 
infectious HCMV challenge decreased the inhibitor production over time to a similar extent. 
Thus this effect appeared to be independent of the infectivity of the virus. This differs from 
the observations in promonocytic U-937 cells where little impact on the inhibitor production 
was seen.
Some factors derived from the HCMV-infected fibroblast cultures seemed to be also 
involved in the regulation of inhibitor production by promonocytic U-937 (Figure-25).
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There have been few reports of growth inhibitors derived from non-monocyte cell lines. 
Scala et al. (1984) reported that ROHA-9 cell line, an EBV transformed human cells, 
produced an alleged contra-IL-1 factor with an apparent molecule weight of 95 Kd. Contra­
IL-1 inhibited the response of murine thymocytes to suboptimal dose of Con A and the 
response of human peripheral blood lymphocyte to streptolysin O or to alloantigen. Walsh 
et al. (1986) demonstrated an so-called IL-1 suppressor factor in a human gingival 
Langerhans cell culture. This factor inhibited the thymocyte response to IL-1 and 
neutralised the effects of IL -1 on both thymocytes and Langerhans cells. However, at 
present, there is no information available concerning the factors derived from HCMV- 
infected fibroblasts which affect the cytokine production by myeloid cells.
4.1.5 The effects of HCMV challenge on the proliferation o f U-937 and 
THP-1 cells
HCMV infection, although frequently occurring in the context of pre-existing 
immunosuppression, may itself exert immunosuppression (Rodgers et al., 1985). Evidence 
has suggested that this immunosuppression may be mediated by monocytes and their tissue 
counterpart macrophages (Rinaldo e ta l , 1980; Carney eta l., 1981). Immunosuppression 
could be resulted from either cytopathic effects in immunocompetent cells (Garnett, 1981; 
Popovic et al., 1984; van Bruggen et al., 1989), or associated with unobservable 
cytopathology (Casali e ta l ,  1984).
HCMV is capable of infecting progenitor cells in bone marrow and monocytes in peripheral 
blood (Neiman et al., 1973; Bechorner et al., 1980). This is sometimes followed by the 
establishment of latency in some of these cells. A latent infection can be established in 
human mononuclear cells after in vitro infection with HCMV, with restriction of virus gene 
expression to IE and early proteins. The frequency of cells expressing IE gene product 
ranges from 0 to 5% depending on the strain of virus and the cell type used (Dudding et al., 
1989). In spite of the low frequency of infection and the lack of a full cycle of replication in 
cells, the impaired functions of the infected cells have been repeatedly reported (Garnett,
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1981; Hayashi et al. , 1985; Price et al.y 1987; Allen, 1987). However no information 
concerning the effects of HCMV infection on myeloid cell proliferation/differentiation has 
ever been provided.
The knowledge gained from HCMV infection of non-monocytic cell lines and in vitro 
models of other viral infections may provide some information in this regard. In vitro 
studies of viral leukemogenesis have indicated that continued presentation of free virus or 
cell surface viral glycoprotein stimulated the proliferation of productively infected myeloid 
cells (McGrath and Weissman, 1978; Teich and Dexter, 1978). Enhanced cellular DNA 
synthesis and stimulated proliferation of quiescent fibroblast cells by HCMV infection have 
also been described (Ho, 1991). These may result from an increased transcription of 
cellular genes as it has been reported that HCMV infection of the productive human 
fibroblast cells could induce an increase in the transcriptional activity of cellular oncogenes 
(Boldogh et al., 1991). However these pieces of information do not exclude the possibility 
that the proliferation response from nonproductively HCMV-challenged myeloid cells may 
be totally different from those observed in the productively infected cells.
Data presented in the present study indicate that HCMV challenge results in suppression on 
the proliferation of U-937 and THP-1 cells (Figure 5, 7, 8, 21 and Table 3). HCMV- 
challenged cells proliferated slower than did unchallenged cells when measured by the 
counts of viable cell number and the level of [3H]TdR incorporation. Mocarski and Stinski 
(1979) reported that HCMV infected nonproductive fibroblast cells incorporated relatively 
low levels of [35S] methionine and the generation time of these cells was four to sixfold 
longer when compared to uninfected cells, indicating that the metabolic activity of these 
nonproductively infected cells was reduced to a low level. The synthesis of some 
substances necessary for cell proliferation was affected, resulting a decreased cell 
proliferation. The decreased metabolic activity could result from a metabolic derangement in 
these cells due to a HCMV infection (Kapasi and Rice, 1988).
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This suppression on the proliferation of U-937 and THP-1 cells did not depend on the 
infectivity of the virus. It appeared to be closely related to some components of the HCMV 
particle, as challenge of these cells with infectious and UV-inactivated HCMV both resulted 
in a similar inhibition of cell proliferation. Some membrane-associated alterations may be 
initiated by the binding of HCMV virions to the cell, as it has been reported that a 
modification of the cell membrane can occur as early as 24 hr after the initiation of HCMV 
infection (Stinski et al., 1979). In fibroblasts, membrane permeability is also altered at IE 
time after HCMV infection (Rugolo et al., 1986). Albubaker et al. (1990 a, b) reported that, 
following exposure of fibroblasts to HCMV, there was a rapid increase in the cellular level 
of 1,2 - diacylglycerol and inositol 1,4,5 - triphosphate and [3H] release from [3H]- 
arachidonic acid prelabelled cells. These effects were dependent on the multiplicity of 
infection, but not the infectivity of the virus. Furthermore, UV-inactivated HCMV infection 
of fibroblasts was able to induce an increase in cellular oncogene RNA levels for fo s ju n  
and mys up to the same level as that induced by infectious HCMV (Boldogh et al., 1991).
As reported by Rasmussen et al. (1991), a HCMV envelope glycoprotein having a 
molecular weight of 86 Kd, gH, had been shown to react with a 92 Kd protein extracted 
from human fibroblasts. But the link between the virus-cell binding and the disturbed 
intracellular metabolism is a matter of speculation at the present time. There are also factors 
in addition to viral attachment governing the intracellular metabolism. The presence of these 
factors may be related to the status of the cell proliferation/differentiation, as shown by the 
results that HCMV challenge did not disturb the inhibitor production by 
differentiating/differentiated THP-1 cell while a reduced production of the inhibition of 
thymocyte proliferation was observed in promonocytic THP-1 cells.
Differentiation signals have been shown to activate viruses from latency to productive 
infection. Weinshenker et al. (1988) reported that monocytic THP-1 cells were infected
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with HCMV with a full cycle of replication after treatment with TPA which induced 
differentiation of the cell line into cells with characteristics of mature macrophages. A 
sim ilar phenomenon was demonstrated for HCMV in differentiated but not in 
undifferentiated human embryol carcinoma cells (Gonczol et al., 1984). In a animal model, 
murine CMV can be activated to productive infection in teratocarcinoma cells only after 
differentiation was chemically induced by dimethylacetamide (Dutko and Oldstone, 1981). 
Data obtained in the present study did not appear to agree with those observations. By 
counting CPE in TCID 50, no detectable level of HCMV yield was observed in the 
supernatants collected at 120 and 144 hr post-challenge from RA-treated U-937 cells.
The replication of HCMV probably requires some cellular functions which may be closely 
related to the phase of the cell cycle. There have been several reports on the influence of the 
cell cycle on virus production. A faster replication of HCMV was obtained when fibroblasts 
were infected in S phase (Furukawa, 1979). Nusiani and Zerbini (1984) showed that 
HCMV transfection performed during S phase was more efficient than during G2 and G1 
phase, respectively. These may suggest that a state of competence have to be established 
before infection.
The inhibitory effect of HCMV challenge on the proliferation of U-937 and THP-1 cells was 
only observed in the cultures which were not treated with RA or in the cells which were 
treated with RA only prior to the virus challenge. It was not surprising to see no further 
suppression on the cell proliferation in which RA treatment was involved after HCMV 
challenge, as both RA treatment and HCMV challenge could suppress cell proliferation. 
Thus, if there were any differences in the cell proliferation between virus challenged and 
unchallenged cells, it could be limited to an undetectable level.
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4.2 CONCLUSIONS AND PROSPECTS FOR FUTURE STUDIES
1) Treatment of U-937 and THP-1 cells with RA at a concentration of 500 nM and for a 
period of 6 days could markedly inhibit the cell proliferation and induce the cells to 
differentiate to become monocyte-like cells. However, a small proportion of less RA 
sensitive cells is present in both cell lines and these may be responsible for the resultant cell 
proliferation after RA is withdrawn from the culture.
2) HCMV challenge of RA differentiated U-937 cells, subsequently cultured with or without 
RA, suppresses cell proliferation and thymidine uptake.
3) UV-inactivated HCMV interferes with replication in RA differentiated U-937 cells 
maintained in RA.
4) HCMV did not alter the growth pattern of THP-1 cells continuously exposed to RA or 
THP-1 cells pretreated with RA before vims challenge.
5) Pro-monocytic U-937 and THP-1 cells spontaneously produce factors which inhibit the 
proliferation of murine thymocytes primed with PHA and rIL-2.
6) After treatment of U-937 and THP-1 cells with RA they become less effective producers 
of suppressor activity for murine thymocyte proliferation, when they are primed with PHA 
and rIL-2.
7) Challenge of U-937 and THP-1 cells with HCMV disturbs their production of an 
inhibitory factor for PHA and rIL-2 primed thymocytes and this disturbance depends on the 
differentiation status of the cells.
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Several questions have been raised during the completion of the study. Firstly, the 
influence of the cell cycle. The cell cycle is not only important in determining the 
consequences of the virus challenge, but also important in the understanding of the 
phenomenon of the virus-induced suppression of cell proliferation. With the aid of Flow 
Cytometry, it would be possible to ascertain the phase of the cell cycle in which cells were 
blocked by HCMV challenge.
Secondly, the nature of the inhibitor(s) produced by U-937 and THP-1 cells in the present 
study. A family of inhibitors of IL-1 and IL-2 has been reported (Section 1.3.6). The 
inhibitory effect documented in the current project was only demonstrated to suppress 
murine thymocyte proliferation when these cells were primed by PHA and rIL-2. It is 
necessary also to demonstrate whether there is an inhibitory effect on thymocyte 
proliferation when IL-1 is added. This knowledge will be helpful in understanding the 
inhibitor production by U-937 and THP-1 cells under the conditions which involve the RA 
treatment and HCMV challenge.
The third area for further study is the impact of the interaction between HCMV and the cells 
used in this study. The suppression of cell proliferation of U-937 cells, which have been 
induced to differentiate with RA, appears to be independent of the infectivity of the virus. 
This suggests that either a virion macromolecule is directly involved or that membrane- 
associated alterations initiated by the binding of live or inactive HCMV to the cell may be 
responsible. It would be of great interest to ascertain the involved virion component(s). 
Such investigations require a preparation of highly purified HCMV virions and hence this 
was not furthered in the current study.
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Appendix
Hank's Balanced Salt Solution ( HBSS) 
7.4; Ca2+ and Mg2+ free; 10 x concentrated
Solution A
NaCl
KC1
M gS04-7H20 
Distilled H 20
80.0 g
4.0 g
2.0 g
400.0 ml
Solution B
KH2P04
Na2HP04
Glucose
Phenol red
NaHC03
Distilled H 20
0.6 g 
0.6 g
10.0 g 
0.2 g
3.5 g
500.0 ml
Working Solution
5 ml Solution A + 5 ml Solution B + 90 ml Distilled H2O. Autoclaved and kept at 4°C.
Phosphate Buffer Saline ( PBS: pH 7.0; Ca2+ and Mg2+ free )
NaCl 8.0 g
KC1 0.2 g
KH2PO4 0.2 g
Na2H P04- 12H20 2.9 g
Distilled H20 1.0 L
RPMI 1640 Medium ( pH 7.2 )
RPMI 1640 powder 0.42 g
NaHC03 1.6 g
HEPES ( 10 mM ) 2.4 g
Penicillin 90 mg
Streptomycin 100 mg
Distilled H20  1.0 L
Trypsin-EDTA Solution
Trypsin
Glucose
Ethylenediaminetetraacetic acid ( EDTA )
PBS
0.05 g
0.002 g 
0.02 g
100 ml
For 50x cone, o f the working solution
1 2 5 g trypsin + 0.1 g glucose in 100 ml of PBS. Filter sterilized. 
2. 1 g EDTA in 100 ml of PBS, pH 7.5. Autoclaved
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Undei sterile conditions, 2 ml of trypsin/glucose added to 2 ml of EDTA and 96 ml PBS to 
the final volume of 100 ml of trypsin/EDTA solution.
Trypen Blue
trypen blue powder 
PBS (pH 7.4)
0.5 g 
100 ml
DAPI Stain
DAPI crystals were dissolved in gd H2O to a final concentration of 2.5 mg/ml, aliquoted 
into 0.2 ml volumes and frozen at -200C. When required, 0.2 ml of the stock solution was 
diluted to 10 ml with absolute methanol to a final concentration of 50 mg/ml.
